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Abstract
This review focuses on outlining the toxicity of titanium dioxide (TiO2) particulates in vitro and in
vivo, in order to understand their ability to detrimentally impact on human health. Evaluating the
hazards associated with TiO2 particles is vital as it enables risk assessments to be conducted, by
combining this information with knowledge on the likely exposure levels of humans. This review
has concentrated on the toxicity of TiO2, due to the fact that the greatest number of studies by far
have evaluated the toxicity of TiO2, in comparison to other metal oxide particulates. This derives
from historical reasons (whereby the size dependency of particulate toxicity was first realised for
TiO2) and due to its widespread application within consumer products (such as sunscreens). The
pulmonary and dermal hazards of TiO2 have been a particular focus of the available studies, due to
the past use of TiO2 as a (negative) control when assessing the pulmonary toxicity of particulates,
and due to its incorporation within consumer products such as sunscreens. Mechanistic processes
that are critical to TiO2 particulate toxicity will also be discussed and it is apparent that, in the main,
the oxidant driven inflammatory, genotoxic and cytotoxic consequences associated with TiO2
exposure, are inherently linked, and are evident both in vivo and in vitro. The attributes of TiO2 that
have been identified as being most likely to drive the observed toxicity include particle size (and
therefore surface area), crystallinity (and photocatalytic activity), surface chemistry, and particle
aggregation/agglomeration tendency. The experimental set up also influences toxicological
outcomes, so that the species (or model) used, route of exposure, experiment duration, particle
concentration and light conditions are all able to influence the findings of investigations. In addition,
the applicability of the observed findings for particular TiO2 forms, to TiO2 particulates in general,
requires consideration. At this time it is inappropriate to consider the findings for one TiO2 form
as being representative for TiO2 particulates as a whole, due to the vast number of available TiO2
particulate forms and large variety of potential tissue and cell targets that may be affected by
exposure. Thus emphasising that the physicochemical characteristics are fundamental to their
toxicity.
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The field of nanotechnology is expanding at a tremendous
rate due to the realisation that the properties exhibited by
materials at a 'nano' scale are often exceedingly different
to those demonstrated by bulk forms of the same mate-
rial. Nanomaterials (defined as having at least one dimen-
sion less than 100 nm [1]), of various types and
quantities, are therefore attractive for exploitation within
diverse products, which harness the novel properties
exhibited by materials with nano dimensions. As a result,
an improved understanding of the potential risks (com-
prising of exposure and hazard assessments) of such
materials is required, and in particular, determination of
nanomaterial characteristics that may detrimentally affect
human health (see for example, Maynard et al. [2]). This
knowledge will be useful in managing risk in the future,
by allowing the implementation of specific control meas-
ures for minimising exposure to such materials, perhaps
through the introduction of regulations, or through the
use of alternative materials. This would therefore allow
safety to be built into the design of nanomaterials and
their applications, to allow their safe integration into
products. This hazard review, relating to the toxicity of
titanium dioxide (TiO2) particulates was adapted from a
series of reviews conducted as part of the Engineered Nan-
oparticles: Review of Health and Environmental Safety'
(ENRHES) project, funded by the European Commission
FP7 funding programme http://nmi.jrc.ec.europa.eu/
project/ENRHES.htm. The project aimed to conduct a
comprehensive, and critical review of the available health
and environmental safety data for a variety of nanomate-
rials, in order to determine the current level of under-
standing (relating to nanomaterial toxicity to humans),
and to identify the current gaps in knowledge, thereby
allowing elucidation of the research that should be con-
ducted with highest priority in the future. In addition, the
hazard information generated within this review is to be
combined with a review of the available human and envi-
ronmental exposure data and an evaluation of industrial
activity in this area, in order to provide the basis for a risk
assessment, based on current knowledge.
Metal oxide nanoparticles (NPs) can be composed of a
variety of diverse materials, including titanium, zinc,
cerium, aluminium and iron oxides. The size of such par-
ticles is integral to their exploitation, but size is also
responsible for prompting concern surrounding their
potential toxicity. When considering metal oxide particu-
lates, the greatest number of available studies have
focussed on revealing the toxicity of TiO2, due to its wide-
spread exploitation. These studies will therefore constitute
the focus of this review. TiO2 exposure, via the pulmonary
route, has been considered with particular interest due to
its use as a (negative) control particulate when assessing
the pathogenicity of other particulate materials such as
alpha-quartz (see below), but also due to concern regard-
ing occupational exposures. Assessing TiO2 particle toxic-
ity to the skin has also formed the focus of a number of
studies, due to their inclusion within sunscreens and cos-
metic products. The ingestion of TiO2 is also of relevance
due to its incorporation into foods and medicines.
Concern about the potential toxicity of nanoparticles in
general, and TiO2 in particular, originally emanates from
the studies conducted by Ferin et al. [3,4] and Oberdorster
et al. [5]. These investigators first demonstrated that pul-
monary inflammation, particle retention and transloca-
tion of ultrafine (equivalent to NPs, in terms of size) TiO2
was enhanced, compared to that of its larger, fine equiva-
lent. Previously, TiO2 has been largely used in pulmonary
toxicology studies as a negative control when assessing the
toxicity of pathogenic particulates such as alpha-quartz.
As a result, this had to be re-considered based on the
apparent size dependency of TiO2 toxicity. These studies
paved the way for the consideration of particle size, in
relation to the toxic response that is manifested by partic-
ulates. More recently, studies have continued to focus on
the importance of TiO2 particle size (and surface area) to
particle toxicity, but have now expanded considerations
to include determining the contribution of the particle
crystal phase, surface chemistry, and photoactivity to their
toxic potential.
In vivo assessment of TiO2 toxicity
In general, in vivo investigations that evaluate the toxicity
of TiO2 particles concentrate on a particular route of expo-
sure, which is driven by the anticipated application of
TiO2, for example the utilisation of TiO2 containing sun-
screens has prompted investigations into the dermal tox-
icity of TiO2.
Pulmonary exposure to TiO2 particulates
The greatest number of available studies, by far address
the consequences of the exposure of the lungs to TiO2. In
particular, the size dependence of any effects has been pri-
oritised within available investigations. In addition, con-
sideration of the contribution of the experimental set up
to the observed toxicity has also been a focus of a number
of studies. A summary of the pulmonary toxicity of TiO2
can be found in table 1.
As mentioned previously, a study conducted by Ferin et al.
[3] was one of the first to demonstrate that particle size
was fundamental to the pulmonary toxicity of TiO2. In
this study, rats were exposed via inhalation, to 21 nm
(23.5 mg/m3) and 250 nm (23.0 mg/m3) TiO2 for 12
weeks, and examination of the consequences of TiO2
exposure evaluated over a 64 week post-exposure period.
Alternatively, rats were administered TiO2 of various sizes
(12, 21, 230 and 250 nm in diameter) via a single intrat-Page 2 of 27
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Paper Particle Model Endpoints Findings
Ahn et al., [14] TiO2 (0.29 μm) Intratracheal Instillation 
(4-72 hour exposure)
-rats
BALF cell infiltration
Number of goblet cells
Muc5ac expression 
(indicative of mucus 
secretion)
IL-13 production
Histology 
(for lung tissue morphology)
Increased neutrophils, 
eosinophils & goblet cells
Increased Muc5ac expression
Increased IL-13
Renwick et al., [6] TiO2 (29 & 250 nm) Intratracheal Instillation 
(24 hour exposure)
-rats
Inflammation (BALF analysis)
Epithelial cell damage
Lung permeability 
(BALF protein)
Cytotoxicity (BALF LDH)
Macrophage phagocytic ability 
(determining the uptake of 
fluorescent polystyrene 
particles)
Macrophage chemotaxis 
(ability to migrate towards 
C5a)
NPs induce a neutrophil 
infiltration
NPs damage epithelial cells
Increased Lung permeability
Increased Cytotoxicity
NPs impair macrophage 
phagocytosis
NP treated macrophages 
increased chemotaxis
Chen et al., [12] TiO2 
(18-21 & 180-250 nm)
Intratracheal Instillation 
(3 day to 2 week exposure)
-mice
Morphological analysis 
(included investigation of 
enlarged alveoli, disrupted 
septa, thickened alveoli)
Apoptosis in lung tissue 
(TUNEL assay)
Immunohistochemical staining 
(antiPCNA)
cDNA microarray analysis
rtPCR & Western Blot (for 
placenta growth factor 
(P1GF))
Morphology of lung injury was 
emphysema-like for NPs.
Observed macrophage 
infiltration that were particle 
laden
Increased apoptosis in lung 
tissue
Gene expression (chemokines 
& complement) changes 
indicative of an inflammatory 
response
P1GF (a cytokine inducer) 
expression anticipated to be 
central to the inflammatory 
response
• No pathology observed for 
fine particles
Warheit et al., [11] TiO2 
(in various crystal forms)
Intratracheal instillation 
(24 hours to 3 month 
exposure)
-rats
Inflammation 
(BALF cells & cytokines)
Lung permeability 
(BALF protein)
Cytotoxicity (BALF LDH)
Epithelial cell secretory 
activity (alkaline phosphatase)
Lung histopathology
Neutrophil infiltration
No cytotoxicity, protein, 
alkaline phosphatase and lung 
morphology changes
Macrophage accumulation but 
normal
• Crystallinity of sample impacts 
on pulmonary toxicity (greater 
toxicity for anatase containing 
particles)
Bermudez et al., [8] TiO2 (1.40 μm) Inhalation 
(13 week exposure)
-mice, rats, hamsters
Inflammation 
(BALF & Histology)
Lung particle burden
Cytotoxicity (LDH) & 
permeability (protein)
High concentrations of particles 
administered impaired their 
clearance from the lung. 
However, hamsters were able 
to most efficiently clear 
particles.
Inflammatory response evident 
in all species, but was most 
severe and persistent in rats.
Increased LDH & protein 
(least severe in hamsters)
Species differences, and dose 
dependent effects observedPage 3 of 27
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(13 week exposure)
-mice, rats, hamsters
Inflammation 
(BALF & Histology)
Lung particle burden
Cytotoxicity (LDH) & 
permeability (protein)
Retained particle burden 
decreased with (post-exposure) 
time & particles contained in 
macrophages
Increased cellular infiltration 
(macrophages and neutrophils) 
dependent on species
Increased LDH & protein 
(not hamsters)
• Findings dependent on species 
(rats>mice>hamsters) and 
particle concentration
Heinrich et al., [13] TiO2
(also diesel soot and ufCB 
treatment groups)
Inhalation (2 year exposure 
(with satalite groups at 3, 6, 
12 & 18 months), with or 
without subsequent clean air 
exposure for 6 months post 
particle exposure)
-rats and mice
Histology 
(to assess Carcinogenicity)
DNA adducts
Lung particle burden
Alveolar lung clearance
BALF cytology and 
biochemical (including LDH, 
protein) analysis
Increased mortality with TiO2 
(although mortality was also 
high in the control group)
Alveolar lung clearance 
compromised by TiO2
Increased protein, LDH in BALF
Increased lung tumours
Ferin et al., [3] TiO2 
(12, 21, 230 & 250 nm)
Intratracheal instillation 
(24 hour exposure)
Inhalation 
(12 week exposure)
-rats
Inflammation (BALF 
neutrophil infiltration & 
histology)
Lung burden & particle 
clearance
Neutrophil infiltration 
(greater for smaller particles)
Particles internalised by alveolar 
macrophages
Particle clearance slower for 
smaller particles, and access the 
pulmonary interstitium to a 
larger extent than fine particles
Grassian et al., [10] TiO2 (5 & 21 nm) Inhalation (4 hour exposure 
will observations made 
immediately or 24 hours 
post exposure)
Nasal instillation 
(24 hour exposure)
-mice
Inflammation 
(BALF cells & cytokines)
Cytotoxicity (BALF LDH)
Lung Permeability 
(BALF protein)
Lung histopathology 
(inflammation, lung injury, and 
abnormalities in pulmonary 
architecture)
Inhalation: macrophage 
infiltration, no changes in 
protein, LDH & histopathology
Nasal instillation: neutrophil 
infiltration, increased IL-1β, IL-
6, protein and LDH for 21 nm 
NPs only
• 21 nm NPs more toxic than 5 
nm NPs 
(due to agglomeration 
differences)
Warheit et al., [9] 6 samples of TiO2 (of 
various surface coatings, 
size up to 440 nm)
Inhalation (4 week exposure, 
with observations made at 2 
weeks to 1 year post 
exposure)
Intratracheal instillation 
(24 hours to 3 month 
exposure)
-rats
Inflammation (BALF)
Lung permeability 
(BALF protein)
Cytotoxicity (BALF LDH)
Histopathology
Inhalation: particle containing 
macrophage accumulation, 
epithelial cell hyperplasia, 
fibrotic response 
(collagen deposition)
Intratracheal: neutrophil 
infiltration, particle laden 
macrophages, increased lung 
permeability, ncreased 
cytotoxicity
• Surface treatment paramount 
to toxicity: aluminia and silica 
coatings increase toxic potency
• The pulmonary toxicity of the 
particle panel overall was low & 
was similar in inhalation and 
instillation set ups
Table 1: The pulmonary toxicity exhibited by TiO2 (Continued)Page 4 of 27
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investigations made 24 hours post-exposure. Following
intratracheal or inhalation exposure, nanoparticulate
TiO2 induced a greater pulmonary inflammatory response
(characterised by neutrophil infiltration), than its micro-
particulate (250 nm) counterpart, which did not elicit any
changes in the inflammatory status of the lung. The
smaller sized TiO2 particles were also found to remain
within the lung for longer periods (501 days) following
inhalation, than the larger TiO2 particles (174 days). This
demonstrates that the clearance of smaller particles from
the lung was slower. In fact, the prolonged retention of
smaller TiO2particles in the lung was suggested to derive
from the finding that they were able to translocate to the
pulmonary interstitium more efficiently than the larger
TiO2 particles. The authors proposed that this phenome-
non was facilitated by the fact that smaller particles were
not efficiently taken up by alveolar macrophages, which
thereby allowed for their prolonged interaction with alve-
olar epithelial cells. It was found that an increased mass
dose (which translates to an increased number of parti-
cles, for smaller particles) promoted the movement of
particles within the pulmonary system. It was therefore
observed that particle size, and the number of particles
administered (which was related to the delivered dose)
impacted on the translocation process, and therefore TiO2
toxicity. However, since the publication of this study it has
been demonstrated that the surface area of particles is
influential to their toxicity. As such, smaller particles have
a greater surface area than their larger counterparts, and as
a consequence exhibit greater toxicity, when administered
at an equal mass dose.
The size dependency of TiO2 (and carbon black (CB)) tox-
icity was investigated by Renwick et al. [6]. To achieve this,
particle mediated inflammatory responses were investi-
gated, and the ability of the particles to impact on clear-
ance mechanisms within the rat lung determined. Rats
were exposed to particles via intratracheal instillation, at
125 μg/rat or the relatively high dose of 500 μg/rat, and
toxicological investigations conducted at 24 hours post
exposure. At the highest dose only, nanoparticulate (29
nm), but not microparticulate (250 nm) TiO2 stimulated
the recruitment of neutrophils into the lungs, epithelial
damage, increased permeability of the lung epithelium,
and cytotoxicity, which were measured within the bron-
choalveolar lavage fluid (BALF). The NPs were also able to
diminish the phagocytic ability of isolated rat alveolar
macrophages (from exposed animals), and increase the
ability of these macrophages to migrate towards the
chemotactic signal, C5a. The authors suggested that the
consequences of such a stimulation would be to promote
the retention of macrophages, and therefore their particle
burden, within the lung. The NPs were therefore demon-
strated to elicit a greater pulmonary inflammatory
response than their larger counterparts.
In a different approach, Bermudez et al. [7] determined if
the choice of species was able to influence the pulmonary
response to nanoparticulate TiO2 (21 nm). This was
achieved through the exposure of rats, mice and hamsters,
to TiO2 NPs, via inhalation, for 13 weeks (6 hours/day, 5
days/week) at concentrations of 0.5, 2, or 10 mg/m3. The
pulmonary response was assessed up to 52 weeks post
exposure, and included assessment of inflammation,
cytotoxicity, lung cell proliferation and histopathological
analysis. It was demonstrated that a pulmonary inflam-
matory response was stimulated by TiO2 within mice and
rats, but was absent in hamsters. The nature of the
response was also observed to vary within the different
species. Specifically, a greater neutrophillic response,
which decreased with time, was apparent in rats, with pro-
gressive epithelial fibroproliferative changes also appar-
ent. In mice, there was neutrophil and macrophage
component of the inflammatory response, and these cell
populations remained elevated throughout the observa-
tion time. The severity of the response was ranked in the
following order, by the authors; rat>mouse>hamster.
Consequently, the rat was found to be the most sensitive
species to the effects of TiO2. The limited toxicity apparent
within hamsters was thought to derive from the low lung
burden of particles, as hamsters had the greatest propen-
sity to efficiently clear particles from the lung. However,
for mice and rats, the initial retention of particles was sim-
ilar, and decreased with time, demonstrating that the pul-
monary clearance kinetics varied amongst the different
species. The study highlights that differences in the
response, and therefore sensitivity of different species are
worthy of consideration within investigations, and the
model which mimics the human situation most accu-
rately requires assessment. It is also of note that the effects
observed were dose dependent, and so the toxicity of NPs
was enhanced by increasing the concentration. The find-
ings demonstrated within this study were comparable
with those of a companion study conducted by Bermudez
et al. [8]. In this study rats, mice and hamsters were
exposed to fine TiO2 particles (1 μm), via inhalation, at
concentrations of 10, 50 or 250 mg/m3, with the experi-
mental design identical to that described previously [7].
Again, species differences were witnessed, so that some
species were most susceptible to particle exposure
(rat>mouse>hamster), in addition to evidence that the
pulmonary toxicity observed was concentration depend-
ent. However, it is difficult to distinguish if size dependent
effects were observed within these separate studies. This is
derived from the utilisation of a higher dose of particles
within the microparticulate study, when compared to
those encountered within the NP study. However, as no
effects were elicited by fine TiO2 particles when adminis-Page 5 of 27
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assume that the NP sample is more toxic, when adminis-
tered at the same mass dose, as toxic effects were observed
at this dose for NPs. In fact, the concentration of particles
used were exceptionally high in both studies, and thus
their physiological relevance is questionable (see later).
However, the authors aimed to achieve a particle overload
situation (see later), so that the administration of high
particle concentrations was undertaken to investigate the
efficiency of clearance processes in the different species,
and thus the experimental set up can therefore be justi-
fied.
The ability of the experimental set up to influence the pul-
monary response to TiO2 was also investigated by Warheit
et al. [9]. It was determined if the exposure method, or
TiO2 formulation (specifically concentrating on surface
coating modification) were able to impact on their pul-
monary toxicity within rats. For inhalation, rats were
exposed to particles (ranging from 290 to 440 nm in
diameter) at concentrations of up to 1300 mg/m3, for a
duration of 4 weeks. In general, following inhalation of
TiO2, there was an accumulation of particle containing
macrophages within the lungs. Following intratracheal
instillation (up to 10 mg/kg) it was observed that some
TiO2 preparations were able to stimulate a transient, pul-
monary inflammatory response that was typified by the
infiltration of neutrophils, and lactate dehydrogenase
(LDH) release, and that this response was resolved within
one week post-exposure. It is relevant that the response
that transpired following particle exposure was very much
dependent on the TiO2 formulation in question. Specifi-
cally, the samples that contained the highest alumina or
amorphous silica content elicited the greatest adverse pul-
monary response. Overall, both exposure methods were
associated with minimal adverse effects, but this may be
derived from the size of particles utilised, as all samples
were out-with nano dimensions (i.e. >100 nm). It must
also be noted that the concentrations of particles admin-
istered in this experiment are deemed to be excessive, and
therefore the relevancy of the findings are questionable.
The utilisation of high particle concentrations is a com-
mon problem within this field of research, as they are not
expected to be encountered within humans, and thus this
issue will be discussed in greater detail later.
Similarly, Grassian et al. [10] investigated what particle
attributes drove the toxicity of TiO2 NPs (5 and 21 nm)
within mice, subsequent to inhalation (0.7 or 7 mg/m3,
for 4 hours with toxicological observations made immedi-
ately and 24 hours post exposure) or nasal instillation (up
to 12.7 μg/mouse). An elevated macrophage population
was associated with the inhalation of particles, and these
cells were observed to internalise particles. An infiltration
of neutrophils, was associated with the nasal instillation
of TiO2. In both exposure scenarios, the response induced
by 21 nm particles was greater than that exerted by their 5
nm counterparts. Consequently, the surface area of parti-
cles was not deemed to be the sole determinant of TiO2
toxicity, which was unexpected. Instead, the crystallinity
of the samples was suggested to influence the toxicity of
TiO2 (see later), as 5 nm particles were pure anatase,
whereas the 21 nm particles were a mixture of rutile and
anatase forms of TiO2. It is also relevant that the nature of
the response varied for the different exposure methods,
specifically inhalation exposure promoted a macrophage
driven response, and instillation exposure triggered the
development of a neutrophil driven response. This insin-
uates that the experimental set up influences the results of
toxicity tests, and may be related to differences within
their distribution within the lung following exposure,
which requires further investigation.
In line with these findings, Warheit et al. [11] aimed to
determine if the crystalline form of TiO2 was able to influ-
ence its pulmonary toxicity within rats, subsequent to
intratracheal administration (1 or 5 mg/kg). Two rutile
NP samples, a 'mixed' NP (80% anatase, 20% rutile) sam-
ple, and a microparticulate rutile (negative particulate
control), in addition to α-quartz sample (included as a
positive particulate control) were considered. All TiO2
particle samples were highly agglomerated (>2000 nm),
following their dispersion in phosphate buffered saline
(PBS), despite the fact that their primary particle size was
less than 100 nm. The pulmonary response to the particle
panel was evaluated up to 3 months post exposure.
Although quartz had the greatest inflammogenicity, it was
evident that several TiO2 particle types elicited a short-
term, pulmonary inflammatory response that was charac-
terised by the infiltration of neutrophils, and was greatest,
and more sustained for the mixed NP sample. Further-
more the only samples capable of eliciting a release of
LDH (a measure of cytotoxicity) and protein (indicative of
increased vascular permeability) into BALF were quartz
and the mixed TiO2 sample. The properties responsible for
driving TiO2 toxicity were then considered and it was sug-
gested that differences in particle surface area accounted,
in part, for the responses exhibited by particles. Accord-
ingly, the mixed sample had the greatest surface area (53
m2/g), and therefore greatest reactivity, so that surface
properties were suggested to drive TiO2 toxicity. However
as the rutile NP samples had surface areas of 18.2 m2/g
and 35.7 m2/g, and the TiO2 microparticles had a surface
area of 5.6 m2/g, it was expected that the rutile NP particle
samples would exhibit an intermediate level of toxicity
(between the mixed, and microparticulate samples), but
this did not transpire within the findings. Therefore, addi-
tional factors were speculated to contribute to the toxicity
of TiO2 particulates, besides their surface area, such as
crystallinity. It was suggested that the rutile NP samplesPage 6 of 27
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tase (see later). In addition, the authors suggested that
post production processing, that removed chloride from
the particle surface, and enhanced agglomeration of parti-
cles, may also contribute to the reduced toxicity of the
rutile NP particles. Again, the particle concentrations
administered were excessively high, and unlikely to be
encountered by humans, and therefore justification of
such concentrations is required by investigators, in order
to determine their relevancy.
The nature of the pathological response associated with
the pulmonary exposure to TiO2 has been studied by a
number of investigators. Chen et al. [12] exposed mice,
via intratracheal instillation (0.1 and 0.5 mg/mouse), to
nano (19-21 nm) and micro (180-250 nm) forms of TiO2.
Pulmonary toxicity was determined 3 days, 1 week or 2
weeks post exposure. Histological assessment illustrated
that morphological alterations within the lung were evi-
dent on exposure to nanoTiO2, which were emphysema-
like in nature (including, for example alveolar enlarge-
ment). Lesions were more pronounced in areas where par-
ticles preferentially accumulated, and increased in
severity, with increasing time and dose. An inflammatory
response, recognised by the infiltration of macrophages
(that were particle laden), upregulation of cytokines
(including monocyte chemotactic protein (MCP)-1, inter-
leukin (IL)-1, tumour necrosis alpha (TNFα) and several
neutrophil chemoattractants) and complement activation
was also observed. Despite the large doses used, no path-
ological lesions were found in response to microparticu-
late TiO2. This study again illustrates the size dependent
toxicity exhibited by TiO2, and the tissue lesions, and bio-
chemical markers associated with the particle toxicity.
In a different approach, Heinrich et al. [13] exposed rats
to P25 TiO2 NPs (size reported by others to be 21 nm (see
for example Ferin et al [3]) via inhalation for 2 years. Par-
ticle exposure was followed by exposure to clean air for 6
months. In addition, mice were exposed to TiO2 for 13.5
months then clean air for 9.5 months. TiO2 was able to
increase mortality within rats and mice, so that their life-
time was significantly shortened. Lung tumours were
observed in both species, as a consequence of the chronic
exposure to TiO2. The high doses utilised in this experi-
ment undermines the relevancy of the findings In fact,
they are likely to represent particle 'overload' conditions,
where the lung is overwhelmed by particle presence to
enhance the toxicity that is manifested. Overload can be
described as the deposition of particles that exceeds the
ability of macrophages to remove them. As a conse-
quence, particles are more likely to be retained within the
lung, and interact with the different lung cell populations
to stimulate toxicity, such as tumour development. This
study therefore highlights how the experimental set up
has the ability to influence the findings (see later). Conse-
quently, TiO2 cannot be regarded as carcinogenic based
on the findings from this study. Therefore, it is anticipated
that the administration of excessively high concentrations
of particles was responsible for promoting tumour devel-
opment within this model, and not an inherent genotoxic
property exhibited by TiO2 particles.
Ahn et al. [14] investigated what processes were responsi-
ble for particulate mediated stimulation of excessive
mucus secretion within humans. To achieve this, TiO2 (4
mg/kg, 0.29 μm diameter) was exposed to rats via intrat-
racheal instillation, and toxicological observations made
from 4 to 72 hours post exposure. TiO2 exposure stimu-
lated an increase in goblet cell hyperplasia, which is, in
part, attributed to an increase in muc5 gene expression
and IL-13 production. Therefore, it could be speculated
that particle mediated increases in mucus secretion can
contribute to the aggravation of chronic airway disease
symptoms within humans, and therefore warrants further
investigation.
The ability of TiO2 exposure to influence the pulmonary
toxicity of known inflammogenic agents has been investi-
gated by Inoue et al. [15]. The impact of TiO2 (15, 50, 100
nm) intratracheal instillation (8 mg/kg) on lipopolysac-
charide (LPS) mediated pulmonary inflammation in mice
was determined. Combined TiO2 and LPS treatment was
able to exacerbate LPS mediated inflammation (indicated
by keratinocyte chemoattractant (KC), IL-1β and MCP-1
production). Circulating cytokines were also increased, as
well as coagulatory factors such as fibrinogen. As observed
previously, there was a size dependency to the findings
was also observed, whereby smaller particles were most
toxic.
In a different approach, Nurkiewicz et al. [16] determined
the impact of TiO2 particles (1 μm) or ROFA particulate
matter on the systemic microvasculature, following intrat-
racheal instillation of rats (0.1 or 0.25 mg/rat, for 24
hours). The authors therefore encompassed the possibility
that systemic effects were a component of the pulmonary
response to particulates. Particle exposure stimulated a
neutrophil influx into the lungs, but no cytotoxic
response was evident. Particles were able to induce an
impairment of endothelium dependent arteriolar dila-
tion. The response was suggested to be related to increased
neutrophil adhesion to the vessels, myleoperoxidase
(MPO) deposition, and oxidative stress within the vessel
wall. These findings are of concern, as they indicate that
an inflammatory response may be stimulated within the
vessel. However, the response was independent of the
level of pulmonary inflammation, and was not thought to
be reliant on the migration of particles from the lung. This
study highlighted the systemic (inflammatory mediated)Page 7 of 27
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this time the mechanisms underlying this response is
unknown.
Consideration of the fate of TiO2, subsequent to pulmo-
nary exposure has been apparent within a number of
investigations, with a particular focus on the transfer of
particles to the brain. Wang et al. [17] investigated the dis-
tribution of rutile (80 nm) and anatase (155 nm) TiO2
particles within the mouse brain, following nasal instilla-
tion exposure (500 μg/mouse, every other day, for a total
of 30 days) and determined if any neurotoxicity was asso-
ciated with exposure. Both forms of TiO2 were able to
access the brain, with accumulation within the cerebral
cortex, thalamus and hippocampus evident, and postu-
lated to occur via the olfactory bulb. This route of uptake
however, was unlikely to be mediated via penetration into
the cardiovascular system and via the blood. Instead, TiO2
delivery to the brain was speculated to occur via neuronal
transport. Accumulation of TiO2 resulted in morphologi-
cal alterations and loss of neurones in the hippocampus,
which was accounted for by the higher distribution of
TiO2 within this brain region. In addition, it was suggested
that TiO2 elicited oxidative stress within the brain due to
elevated catalase activity, decreased superoxide dismutase
(SOD) activity and evidence of increased lipid peroxida-
tion and protein oxidation. Therefore neuronal mediated
translocation of TiO2 to the brain, following nasal instilla-
tion, was observed, with the hippocampus illustrated as
being the main target of accumulation and toxicity. Wang
et al. [18] expanded upon these findings and found that
the phenomenon was time dependent (maximal at 30
days), and that an inflammatory response (indicated by
IL-1β, and TNFα) within the brain was also stimulated by
TiO2 exposure. The response was measured at day 2, 10,
20, and 30. It was apparent that repeated exposures, over
a period of 30 days, were required to enable the accumu-
lation of TiO2 within the brain. It is therefore of interest
that the neuronal transport of NP containing substances
between the nose and CNS could be exploited, in order to
bypass the blood brain barrier, but that the stimulation of
an inflammatory response may be associated with this
phenomenon.
The results of the outlined studies imply that the toxic
potential of TiO2 was primarily dictated by particle size,
and crystallinity; whereby decreasing particle size, and
anatase forms of TiO2 were observed to enhance particle
pulmonary toxicity. In addition, it is suggested that the
experimental model (including species used, exposure
method and dose administered) was able to impact on the
toxicity of TiO2, which complicates making comparisons
between different investigations. The pulmonary response
to TiO2 has been demonstrated to be inflammogenic; with
a contribution from neutrophils and macrophages (which
are elevated and thought to contribute to particle
removal). In addition, epithelial damage, oxidative stress
and cytotoxicity are also common findings. In addition,
chronic exposure to TiO2 also has the ability to promote
tumour development, illustrating their carcinogenic
potential, but this is only likely to manifest when admin-
istered in particle overload conditions.
Intraperitoneal exposure to TiO2
Chen et al. [19] investigated the acute toxicity of nano-
TiO2 (80-100 nm) subsequent to the intraperitoneal injec-
tion of mice. The doses used were exceptionally high
(ranging from 324 to 2592 mg/kg), and it is therefore
unsurprising that mortality was associated with exposure.
TiO2 was observed to block pulmonary vessels, leading to
thrombosis, with pathology also evident within the liver,
spleen and kidneys. This study highlighted the need to
consider the use of realistic doses of particles, as the
observed effects are likely to derive from the high dose of
particles administered, and not the inherent toxicity of
particles.
Dermal exposure to TiO2
Considering the impact of TiO2 dermal exposure is espe-
cially relevant due to its inclusion within sunscreens and
cosmetics that are directly applied to skin. As a conse-
quence, the dermal penetration and toxicity of TiO2 parti-
cles, has been a focus of a number of investigations. The
skin, and in particular, the stratum corneum, is a primary
barrier against the penetration of particles contained
within dermally exposed substances, and therefore its effi-
ciency will also be discussed.
Mavon et al. [20] determined the distribution of TiO2 (20
nm) within the skin in vitro and in vivo. Five hours follow-
ing the direct topical application of TiO2 (2 mg/cm2) to
human skin or to human skin explants tape stripping
(placing and removing adhesive tape onto and from the
skin repeatedly and subsequently analysing the compo-
nents striped from the skin surface) was used to determine
the dermal penetration of TiO2. In vivo, and in vitro, the
majority of the TiO2 was contained within the stratum
corneum, with minimal distribution within the epider-
mis. Therefore in both preparations, TiO2 presence
decreased with increasing depth of the skin, so that the
penetration of TiO2 past the stratum corneum into viable
skin layers was minimal.
Similarly, Schulz et al. [21] determined the influence of
particle size, coating and shape on TiO2 skin penetration.
A number of TiO2 containing sunscreen formulations
were tested that had different particle surface characteris-
tics; trimethyloctylsilane coated (20 nm), or aluminium
oxide (Al2O3) and silica (SiO2) coated (10-15 nm). For-
mulations were topically exposed to human skin at a con-Page 8 of 27
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taken. All particle types were solely located on the outer-
most surface of the stratum corneum, and did not pene-
trate deeper to subcutaneous, epidermis or dermis layers.
In a different approach, Kiss et al. [22] evaluated the bar-
rier function of skin, within human foreskin grafts trans-
planted onto severe immunodeficient mice. A
commercially available TiO2 microparticulate containing
sunscreen was administered (2 mg/cm2) via an occlusive
bandage to skin grafts for 24 hours, and the penetration of
TiO2 determined within skin biopsies. It was found that
TiO2 particles did not penetrate through the stratum cor-
neum of human skin transplants. The stratum corneum
was therefore deemed to be an adequate, effective barrier
against TiO2 penetration in intact human skin. However,
the authors noted that as it is likely that TiO2 exposure
occurs when skin barrier functions may be impaired (such
as sunburn), and as a consequence, TiO2 may come into
direct contact with underlying skin cells, a concept which
has yet to be investigated.
The findings from the available studies demonstrated that
the penetration of TiO2 is negligible within (healthy) skin.
This is important, as NPs appear to be unable to reach the
living cells present within the deeper skin layers, and thus
their propensity for toxicity is anticipated to be minimal.
Therefore, it is relevant, within future studies, to consider
the fate of particles within skin models that take into con-
sideration that sunscreens are often applied to burnt,
damaged and diseased skin, where the barrier function of
the stratum corneum will inevitably be impaired [22,23].
This has been discussed within several investigations but
not actually studied.
Oral exposure to TiO2
Only one study could be identified that addressed the
consequences of oral exposure of TiO2. Wang et al. [24]
investigated the distribution and acute toxicity of nano-
particulate (25 and 80 nm) and microparticulate (155
nm) forms of TiO2 in mice, following oral exposure (5 g/
kg). TiO2 particles of all sizes, 2 weeks post exposure, were
distributed to the liver, spleen, lungs, kidneys, thus pro-
viding evidence that they could be transported to other
sites subsequent to exposure, due to their translocation
into the blood. Within the liver, NPs initiated an inflam-
matory response, with liver damage indicated by a rise in
serum transanimases, and hepatic necrosis was revealed in
histopathological investigations. Markers of cardiac dam-
age were also observed to be elevated by TiO2 NPs, within
the serum. Limited toxicity was associated with micropar-
ticle exposure. This study therefore provided interesting
results. Specifically the potential for TiO2 particle transfer
into the blood from the GIT was demonstrated, which
would necessitate that they are able to pass through the
gut wall. It also revealed that the liver was a primary target
for the toxicity of TiO2. However, the use of an exception-
ally high dose of particles undermines the relevancy of the
results, as such exposure levels are unexpected in humans.
ADME Profile of TiO2
Determining the kinetics of TiO2 within the body, subse-
quent to exposure (via the lungs, gut and skin) is neces-
sary to identify potential targets of toxicity. The delivery of
TiO2 particles from the exposure site to secondary target
organs, such as the liver or brain requires their transfer
into blood, or transport within neurones. Therefore their
likelihood of accessing different organs and tissues within
the body is also necessary to direct appropriate in vitro
investigations at relevant target sites. However, a number
of barriers (at the exposure site and those apparent within
secondary targets) are in place to prevent against uptake,
and it is necessary to determine if they are overcome by
TiO2, to determine its systemic availability.
Only one example of particle translocation into the blood
from the gut could be identified. Specifically, TiO2 NPs
were observed to translocate into the blood, following
oral exposure, and thereafter distribute to secondary tar-
gets, including the liver, spleen, lungs, and kidneys [24].
Studies investigating the dermal penetration of TiO2 sug-
gest that the transport of nanoparticles past the stratum
corneum is negligible, and therefore it is unlikely that the
particles will access the circulation via this route. The lim-
ited penetration of TiO2 NPs within skin has also been
replicated within in vitro models (see later). Wang et al.
[17,18] demonstrated the transfer of TiO2 NPs to the
brain, following intranasal exposure, which occurred via
their transport within neurones.
No evidence of TiO2 metabolism, or elimination from the
body could be identified in the literature at this time.
The translocation of TiO2 particles, subsequent to pulmo-
nary and oral exposure should encompass the possibility
that distal sites are affected; including the CNS, liver, and
cardiovascular system. The translocation is likely to be
due to their passage into blood, but may also be mediated
by neuronal transport. Both these processes would allow
for their transport to targets sites (such the brain), and
within different regions of a particular target (such as dif-
ferent brain regions). In contrast, the penetration of parti-
cles within the skin is negligible, and so particles are
unlikely to become systemically available, following
exposure via this route. The elimination of particles from
the body is also a necessary consideration, which would
provide information regarding the longevity of particles
within the body, and therefore their propensity for dam-
age.Page 9 of 27
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exposure
Following injection, it is necessary to determine particle
distribution to identify potential targets for toxicity. There
are limited available studies that purport to investigate
this. In addition, it is assumed that if NPs gain access to
the circulation following exposure via the lungs, skin or
GIT, a similar distribution pattern is expected, albeit it to
a lesser extent.
Fabian et al. [25] determined the tissue distribution of
TiO2 NPs (20-30 nm) within rats following intravenous
injection (5 mg/kg), 1, 14 and 28 days post exposure,
TiO2 was cleared from the blood and primarily accumu-
lated within the liver, but was also apparent within the
spleen, lungs and kidneys. The level of TiO2 within the
liver was maintained over the observation time, however
levels decreased with time within the other organs. No
serum cytokine or enzyme changes were observed, which
insinuated that no toxicity was associated with TiO2 expo-
sure, however further investigations, including his-
topathological analysis would be necessary to confirm
this.
The only study identified suggested that following intrave-
nous administration, TiO2 particles are cleared from the
blood and are able to accumulate primarily within the
liver, but also the lungs and spleen. This is likely to derive
from their uptake by the resident macrophage popula-
tions, contained within the reticulendothelial system. Fur-
ther investigations are necessary to determine if an
inflammatory or toxic response is associated with such an
accumulation.
In vitro investigations of TiO2 toxicity
Lung models
Investigations that assess the pulmonary toxicity of TiO2
particles in vitro have used a variety of models including
macrophages (due to their contribution to clearance), epi-
thelial cells (due to their abundance, and expected inter-
action with particles) and explanted tissue.
Park et al. [26] investigated the cytotoxicity of TiO2 NPs
(21 nm) to BEAS-2B lung epithelial cells, at concentra-
tions ranging from 5 to 40 μg/ml, for up to 96 hours. A
dose and time dependent decrease in cell viability was
observed. Caspase-3 was activated by TiO2, with chromo-
some condensation also apparent, which was suggestive
that an apoptotic mechanism of cell death was involved.
Reactive oxygen species (ROS) production, glutathione
(GSH) depletion, and increased hemeoxygenase (HO-1)
expression was evident, thereby implying that an oxida-
tive mechanism drove the cytotoxic response. IL-8, IL-1,
IL-6, TNFα, and CXCL2 (neutrophil chemoattractant)
cytokine gene expression was increased, insinuating that
an inflammatory response was also stimulated by TiO2.
The findings therefore indicated that an oxidant driven
response was integral to the toxicity of TiO2, which had
inflammatory and cytotoxic consequences.
Churg et al. [27] determined the impact of TiO2 exposure
(up to 7 days), on the development of a fibrotic response,
within the airway wall on rat tracheal explants. Both
microparticulate (0.12 μm) and nanoparticulate (0.021
μm) forms of TiO2 were investigated. No changes in gene
expression were observed until day 5. NPs stimulated
growth factor expression (such as platelet-derived growth
factor (PDGF)) and enhanced pro-collagen expression.
The authors suggested that the NPs were more fibrogenic,
which is anticipated to contribute to airway obstruction in
vivo. However, TGFα and TGFβ expression was increased
for microparticles only, but no fibrotic-like morphologi-
cal changes occurred, and so it was suggested that these
mediators were not responsible for driving the fibrotic
response mediated by NPs.
Gurr et al. [28] investigated the oxidative damage exhib-
ited by TiO2 (10, 20 or >200 nm) within bronchial BEAS-
2B cells. The oxidative potential of TiO2 was confirmed by
the finding that lipid peroxidation (indicated by increased
malondialdehyde (MDA)) and ROS (hydrogen peroxide)
and reactive nitrogen species (NO.) production were
enhanced by nanoparticulate forms of TiO2. DNA adducts
were only formed following exposure of cells to TiO2 NPs.
The oxidative and genotoxic potential of nanoparticulate
forms of TiO2 was therefore demonstrated to be superior
to that of their larger counterparts.
Simon-Deckers et al. [29] investigated the toxicity of a
panel of particles, including TiO2 (in anatase and rutile
forms, and a variety of sizes) and Al2O3, to A549 cells (a
human carcinoma derived alveolar epithelial type 2 cell
line). In general, the cytotoxicity of the particles was low,
despite the fact that they were internalised by cells, and
contained within cytoplasmic vacuoles or lysosomes.
However, it is noteworthy that it is possible for particles to
be internalised by cells without having a detrimental
impact on normal cell function. The crystal phase of TiO2
was observed to influence the cytotoxicity exhibited by
particles. Specifically, the greater the anatase content of
the sample, the greater the ability to induce cell death. In
addition, the size of NPs was suggested to contribute to
their toxicity, as TiO2 NPs were more toxic than their
larger counterparts. In addition, the chemical composi-
tion of NPs was also thought to impact on their toxicity,
as 12 nm TiO2 NPs were more toxic than 11 nm Al2O3,
despite their similarity in size. Consequently, the size,
composition and crystal phase of particles were all sug-
gested to influence NP toxicity, despite the fact that the
toxicity of NPs used was generally low. Therefore, it isPage 10 of 27
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particles is confounded by differences in other particles
attributes such as the sample phase. Consequently deter-
mining the properties of TiO2 that drive toxicity is diffi-
cult, and therefore isolating a particle characteristic that is
solely responsible for mediating adverse effects is not
likely to be attainable.
Kim et al. [30] assessed TiO2 (1 μm) mediated cytotoxicity
to alveolar macrophages (obtained from rats, via bron-
choalveolar lavage), when exposed to concentrations
ranging from 0.5 to 5 mg/ml, for up to 5 hours. TiO2 elic-
ited a dose dependent decrease in cell viability, which was
suggested to be mediated by suppressed adenosine tri-
phosphate (ATP) generation, and also reliant on the inter-
action of TiO2 with scavenger receptors on the cell surface.
It is relevant that the response of silica particles (1.6 μm)
was also considered. Silica had a greater cytotoxic poten-
tial than TiO2 and the mechanisms underlying the
response were different.
As responses of organs and tissues are likely to involve
interactions between different cell types, it is necessary to
incorporate this within in vitro tests. Barlow et al. [31]
investigated the ability of L2 epithelial cells to modulate
macrophage migration in vitro, on exposure to nano and
microparticulate forms of TiO2 (29 nm and 250 nm,
respectively) and CB (260 nm and 14 nm diameter respec-
tively). TiO2 and CB induced a dose dependent decrease in
epithelial cell viability, which was greatest for NPs (when
exposed at concentrations ranging from 62.5 to 2000 μg/
ml for 24 hours). Conditioned medium (obtained from
epithelial cells treated with particles) was able to increase
macrophage migration, but only for ultrafine carbon
black NPs. Therefore, TiO2 NPs were unable to stimulate
the release of chemotaxins from epithelial cells, which the
authors suggest could be due to their smaller surface area,
when compared to that of ufCB.
From the investigations discussed, it is evident that TiO2
particles are able to detrimentally affect both lung derived
macrophage and epithelial cells. Therefore, in general,
particles mediated oxidative, inflammatory and genotoxic
effects that eventually culminated in cytotoxicity. How-
ever, in some situations there was no evidence of toxicity,
mediated by TiO2. These differences may be derived from
the model used, or the particle under investigation. It is of
interest that the mechanisms driving the toxicity of TiO2
in vitro (particularly inflammation and oxidative stress)
are also witnessed in vivo (see earlier).
Dermal models
The penetration of TiO2 particles within the skin has been
a focus of a number of in vitro investigations due to the
exploitation of particles within sunscreens and cosmetic
products. Gamer et al. [32] evaluated the penetration of
sunscreen formulations containing micron-sized TiO2 (up
to 400 μg/cm2, for 3 to 24 hours) within porcine skin
explants. It was observed that the location of both particle
types was restricted to the stratum corneum following
their topical application. Specifically, particles were
deposited on the skin surface, within the outmost layer of
the stratum corneum, as evidenced by their removal via
washing or tape stripping analysis. There was therefore no
evidence that particles penetrated into the deeper stratum
corneum layers, epidermis or dermis, and thus the barrier
function of the skin was successful in limiting the passage
of particles.
Similarly, Pflucker et al. [33] illustrated that TiO2 NPs (20-
50 nm) did not penetrate porcine skin in vitro. A TiO2
emulsion (4 mg/cm2) was topically applied to excised pig
skin for 24 hours. Skin biopsies were taken following
exposure, and the penetration of particles assessed using
tape stripping. Again TiO2 was exclusively located within
the outermost layer of the stratum corneum, with no dis-
tribution to the underlying living cell layers evident. Con-
sequently, this study suggests that the intact stratum
corneum is an effective barrier to TiO2, and that the pene-
tration of particles within the skin is negligible.
In addition, Dussert et al. [34] investigated the distribu-
tion of TiO2 and ZnO NP containing sunscreen formula-
tions within human skin explants. Again, sunscreens were
topically applied to skin but no penetration of particles, or
intracellular delivery was observed past the stratum cor-
neum skin surface.
The functional implications of the exposure of the various
skin cell populations have also been determined within in
vitro investigations. From the data available for TiO2 parti-
cles, such studies are potentially more relevant to compro-
mised/damaged/diseased skin than normal healthy skin,
due to the negligible penetration of particles within nor-
mal skin. There is therefore a need to consider the distri-
bution of particles within damaged or sunburnt skin,
which would be likely to promote the penetration of par-
ticles, due to damage to the stratum corneum. There is lit-
tle or no data currently available to assess the impact of
such damage on penetration or hazard.
Kiss et al. [22] exposed HaCaT keratinocytes, human der-
mal fibroblast cells, SZ95 sebaceous gland cells and pri-
mary human melanocytes to TiO2 (9 nm diameter), at
concentrations of 0.15 to 15 μg/cm2, for up to 4 days. Par-
ticles were internalised, and evident in the cytoplasm and
perinuclear region of fibroblasts and meloncytes. Particle
uptake was also associated within an increase in intracel-
lular calcium in these cell types. However, no particle
uptake, or alterations in calcium signalling were observedPage 11 of 27
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dependent decrease in cell proliferation was evident
within all cell types, and an increase in cell death (via
apoptosis) within fibroblasts was apparent. The direct
contact of cells with TiO2 particles is therefore of concern,
as it can disturb normal cell functions within the different
skin cell populations, but it is noteworthy that all cell
types were not affected similarly, and thus cell specific
effects are encountered on exposure to TiO2 particles. Kiss
et al. [22] also demonstrated that the stratum corneum
was an effective barrier against micronized TiO2 in vivo
(see earlier). However it would have been of greater inter-
est to determine if NPs are able to penetrate skin, as the in
vitro component of the study illustrated that when in
direct contact with skin cells TiO2 NPs are able to elicit
toxicity.
Jin et al. [35] determined the cytotoxicity of TiO2 (20-100
nm) to mouse L929 fibroblasts at concentrations of 3-600
μg/ml, for up to 48 hours. There was a time and dose
dependent decrease in cell viability induced by TiO2. An
increase in ROS production and decreases in GSH and
SOD activity were observed, thereby implying that oxida-
tive stress was a feature of the response. TiO2 was also
demonstrated to be internalised by phagocytosis, and was
contained within lysosomes. Analysis of cell morphology
illustrated that cell morphology was detrimentally
affected by TiO2, and that cell adhesion and proliferation
was prevented, confirming the decrease in cell survival.
The studies conducted demonstrated that the toxicity of
TiO2 to skin cells is of concern, with oxidative, genotoxic
and cytotoxic consequences evident, and likely to act in
concert. However, in order to execute these effects, parti-
cles would be required to penetrate past the stratum cor-
neum, to reach the underlying cell populations, which is
unlikely to occur in healthy skin (see earlier). As noted
previously, the penetration of particles within damaged
skin should therefore be considered a priority in future
experiments.
GIT models
Only one study could be identified that evaluated the
impact of TiO2 exposure on the GIT, in vitro. Zhang et al.
[36] investigated the contribution of photoexcitation, to
the cytotoxicity of TiO2 (21 nm) within human colon car-
cinoma Ls-174-t cells. Cells were exposed to TiO2 for 24
hours, at concentrations up to 1000 μg/ml. Limited cyto-
toxicity of cells was observed, following TiO2 exposure, in
the absence of ultraviolet (UV)A irradiation. In contrast, a
high level of TiO2 induced cell death was observed in the
presence of UVA light, which was a dose and time depend-
ent phenomenon. Therefore, the toxicity of TiO2 had a
photocatalytic component. Consequently, TiO2 particles
and light irradiation therapy was suggested by the authors
to be a suitable candidate for the treatment of cancer, and
warrants further investigation. However, this may be lim-
ited by the ability of UV light to penetrate the human
body, and the specificity of the response, and so the
exploitation of this for tumour treatment will inevitably
be restricted.
Liver models
Hussain et al. [37] compared the impact of a range of NPs,
including iron oxide (Fe3O4, 30 nm), and TiO2 (40 nm)
on BRL 3A liver cells, at concentrations up to 250 μg/ml,
following a 24 hour exposure. Both particle types were
able to decrease cell viability, but only at the highest con-
centration tested.
Linnainmaa et al. [38] assessed the toxicity of TiO2, in NP
(rutile and anatase (20 nm)), and microparticulate (170
nm) forms) to rat liver epithelial cells, in the presence and
absence of UVA light. No cytotoxicity or chromosomal
damage was observed within cells exposed to all TiO2 par-
ticle types in the presence or absence of UVA.
The two studies that investigated the toxicity of TiO2 par-
ticles to the liver, suggest that TiO2 exhibits a low level of
toxicity to liver cells, but this would require further inves-
tigation to be confirmed, due to the limited number of
liver cell targets considered within the available studies.
The consequences of liver exposure, to TiO2 are of partic-
ular interest due to evidence of preferential NP accumula-
tion within this organ (see earlier).
Cardiovascular models
The interaction of TiO2 with endothelial cells that line
blood vessels has been a focus of investigations, to deter-
mine the consequences of particle transport with the
blood. In addition, the impact of TiO2 on cardiomyocyte
function has been investigated.
Peters et al. [39] evaluated the impact of a NP panel
(including TiO2, 70 nm) on HDMEC endothelial microv-
ascular cell viability and function. Cells were exposed to
TiO2 at concentrations ranging from 0.5 to 50 μg/ml, for
up to 72 hours. NPs were internalised by cells into cyto-
plasmic vacuoles, but minimal toxicity was associated
with this, therefore highlighting that particle uptake does
not necessarily impact on cell function. Consequently,
TiO2 was relatively non-toxic, with no cytotoxicity, and
minimal IL-8 release stimulated by exposure.
Courtois et al. [40] determined the impact of TiO2 (15 nm
or 0.4 μm diameter) exposure on nitric oxide (NO) medi-
ated relaxation of pulmonary arteries in vitro. Pulmonary
arteries were exposed to particles for 24 hours (at concen-
trations up to 200 μg/ml), in the presence or absence of
vascular relaxants. It was found that urban particulatePage 12 of 27
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within intrapulmonary arteries in vitro and in vivo (follow-
ing intratracheal exposure). In contrast, manufactured
NPs, including TiO2 did not exhibit this effect. Therefore
this study suggested that the pulmonary circulation was
not affected by TiO2 exposure, and that cells exhibited dif-
fered in their sensitivity to particles.
Helfenstein et al. [41] observed that TiO2 NPs (up to 125μg/ml, 20-30 nm diameter) were able to affect cardiomy-
ocyte electrophysiology, enhance ROS production, and
reduce myofibril organisation. A panel of particles was
tested, of which diesel exhaust particles (DEPs) were dem-
onstrated to exhibit the greatest toxic potency, and SWC-
NTs were found to have limited toxicity in comparison.
The findings from this study suggest that cardiac cells may
be damaged by TiO2 or DEP exposure, and so were unable
to function normally in vitro.
A limited number of studies have been conducted to
determine the impact of TiO2 particles within in vitro
models of the cardiovascular system. However, the find-
ings suggest that TiO2 may promote an inflammatory
response within blood vessels which has the propensity to
stimulate or aggravate cardiovascular disease. Conse-
quently, the ability of TiO2 to contribute to inflammatory
mediated disease requires further consideration in vivo. In
addition, the ability of TiO2 to negatively impact of cardi-
omyocyte function has the ability to disturb normal car-
diac electrophysiology. Again, further studies, in vivo,
would be required to verify this observation.
CNS models
Long et al. [42] established the contribution of oxidative
stress to the neurotoxicity of TiO2 NPs (30 nm diameter,
but particles agglomerated in culture medium). BV2
microglia cells were exposed to TiO2 for periods of up to
120 mins, at concentrations ranging from 5 to 120 ppm,
and ROS production determined. The oxidative response
mediated by TiO2 within microglia had two components.
Firstly, a rapid increase in ROS production was observed
at 1-5 minutes, and termed an oxidative burst. This was
followed by a greater, sustained ROS release from 60-120
minutes. It is also relevant, that despite having a primary
particle size of 30 nm, the particles were observed to
aggregate within the cell culture medium, which increased
with increasing concentration, and this appeared to pro-
mote ROS production, perhaps due to the greater uptake
of larger structures by phagocytosis. Internalised particles
were found within the cytoplasm. Mitochondria located
in the vicinity of the internalised aggregates were found to
be swollen and disrupted, which was postulated by the
authors to promote an apoptotic or necrotic response.
Similarly, Long et al. [43] investigated the neurotoxicity of
nanoparticulate TiO2 (up to 120 ppm). It was illustrated
that particle aggregates were phagocytosed by BV2 micro-
glial cells, and contained within membrane bound vesi-
cles. ROS production by cells was associated with particle
exposure, and stimulated the upregulation of genes
involved with inflammation, apoptosis, and cell cycling,
and a down-regulation in energy metabolism. It was
therefore evident that increased ROS production as a con-
sequence of TiO2 exposure also triggered cytotoxicity via
apoptosis. However, TiO2 exposure was non-toxic to N27
neuronal cells, following a 72 hour exposure, despite
being internalised. These results reinforce the finding that
particle internalisation does not necessarily equate to the
initiation of a toxic response within cells, and that cell
types differ in their susceptibility to particle toxicity. In
contrast there was evidence of neurone loss within pri-
mary cultures of rat striatum within 6 hours of exposure,
which was suggested to occur via microglia mediated ROS
production.
Information regarding the neurotoxicity of TiO2 is
severely lacking, and restricted to the work conducted by
one research group. However, it is evident that the
response is likely to be dictated by the cell type under
investigation. Again, an oxidant driven response appears
to be integral to particle toxicity. At present, there is insuf-
ficient evidence to make generalisations regarding TiO2
mediated neurotoxicity.
Kidney models
Only one study was found that assessed the toxicity of
TiO2 NPs to the kidneys, in vitro. L'azou et al. [44] investi-
gated the effect of TiO2 (15 or 50 nm) on IP15 mesangial,
and LLC-PK1 proximal tubular epithelial renal cells (at
concentrations up to 512 μg/ml, for 24 hours). The differ-
ent cell types exhibited different sensitivities to the toxic-
ity of TiO2. No cytotoxicity was observed within IP15 cells
on exposure to TiO2. However, TiO2 elicited a cytotoxic
response within LLC-PK1 cells, suggesting that this cell
type was more sensitive to TiO2 toxicity. This was postu-
lated to derive from their high endocytic activity, and
therefore greater internalisation of particles. The cytotoxic
response was also observed to be size dependent, with a
greater response exhibited by smaller particles. TiO2 (15
nm) was also able to induce morphological changes
within both cell types (namely cell shrinkage, and detach-
ment), and was internalised into cytoplasmic vacuoles.
TiO2 was unable to induce an increase in ROS production.
However, 13 nm carbon black NPs were consistently rec-
ognised as being more toxic, in terms of cytotoxicity, and
ROS production, which was evident in both cell types.
Toxicity to renal cells was therefore observed to be particle
size, particle composition, and cell type specific.
The findings from the only study identified as studying
the toxicity of TiO2 particles to the kidneys, suggest that
the response of the individual cell populations vary. How-Page 13 of 27
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if the finding was applicable to other particle types, and if
the same response is evident in vivo. Therefore it is difficult
to draw definitive conclusions about particle toxicity to
the kidney, due to insufficient data being available.
Immune system models
It is acknowledged that macrophages are primarily
responsible for the clearance of particles at sites of expo-
sure, and accountable for the accumulation of particles
within different target sites, which is anticipated to derive
from their role within the reticuloendothelial system. The
consequences of particle uptake by macrophages is there-
fore of interest, particularly the initiation of an oxidative
driven or inflammatory response, and impact on their
phagocytic function. In addition, the ability of particles to
affect other immune cell populations, such as lym-
phocytes, is of interest as particles would be expected to
encounter these cells within the blood.
Renwick et al. [45] determined the impact of particle
exposure on the phagocytic activity of macrophages. It
was observed that TiO2 (and CB) particles were able to
impair J774.2 macrophage cell phagocytic activity (indi-
cated by the uptake of 2 μm latex beads), in a concentra-
tion dependent manner. TiO2 NPs (29 nm) were more
effective at inhibiting macrophage phagocytosis than their
microparticulate (250 nm) counterparts, and the same
response was exhibited by CB particles. It is likely, that the
impairment of phagocytosis occurs as a consequence of
the fact that cells are overwhelmed by the TiO2 particle
burden, and are therefore unable to further internalise the
latex particles. This was suggested to be the case, as an
increase in particle-laden macrophages correlated with a
decrease in phagocytic cells. The impairment in phago-
cytic function of macrophages would be anticipated to
impact on the clearance of particles, thus increasing their
retention, and thereby prolonging their interaction with
cells, and enhancing their propensity for eliciting damage.
Afaq et al. [46] demonstrated that alveolar macrophages
were increased in rats on intratracheal exposure (2 mg/rat,
with observations made for a period of up to 16 days) to
TiO2 NPs (<30 nm), which was maximal at 8 days post
exposure. The exposure of alveolar macrophages to TiO2
was associated with lipid peroxidation, glutathione deple-
tion and enhanced hydrogen peroxide production, illus-
trating the oxidative response that developed. Exposure
was also associated with cytotoxicity.
Kang et al. [47] determined the mechanisms underlying
TiO2 (25 nm) NP toxicity within lymphocytes, at concen-
trations ranging from 20 to 100 μg/ml, for up to 48 hours.
A particular focus of the study was on the oxidative poten-
tial of TiO2. A dose and time dependent decrease in cell
viability was observed. TiO2 NPs also exhibited a genoto-
xic effect, whereby the frequency of micronuclei forma-
tion increased, which insinuated chromosomal damage
occurred on exposure of cells to TiO2. DNA damage was
also observed, using the Comet assay. Importantly, the
pre-treatment of cells with the antioxidant N-acetyl
cysteine (NAC), decreased TiO2 mediated DNA damage,
thereby inferring that the response was ROS mediated.
ROS production was subsequently confirmed to be
increased by TiO2 exposure. The DNA damage inflicted by
TiO2 resulted in the activation of a protective response in
the form of increased levels of p53 protein, highlighting
an attempt of the cells the repair the damage mediated by
TiO2. TiO2 mediated increases in ROS production, and
therefore DNA damage, was thought to be central to its
toxicity within lymphocytes.
Investigation of the impact of TiO2 particle exposure on
immune cell function is lacking. Alveolar macrophages
are recognised as being integral to the removal of particles
from sites of deposition, and are, in the main, responsible
for the accumulation of particles within different target
sites. It is therefore of concern that particles appear to
impair macrophage phagocytosis, and this should be con-
sidered further in future experiments. It is also suggested
that particles initiate an oxidative driven response within
immune cells that may have inflammatory and/or cyto-
toxic consequences.
The biological mechanisms driving TiO2 
nanoparticle toxicity
TiO2 mediated inflammatory responses
Inflammatory responses have been illustrated as being a
prominent feature of a number of studies that investigate
the toxicity of nanoparticles such as TiO2. In vivo, the infil-
tration of neutrophils has been repeatedly demonstrated
to characterise the inflammatory response to TiO2 NPs
[3,6], in addition to elevated, particle laden macrophage
numbers [10,12]. This is likely to be mediated by
increases in inflammatory mediators, such as IL-8, and
TNFα that have been observed in vivo [12] and in vitro
[18]. The inflammogenic nature of TiO2 has been
observed within a number of target sites including the
lung, brain, and cardiovascular system, and so is not an
organ specific observation. Inflammation has been dem-
onstrated to be recurrently associated with TiO2exposure,
with its manifestation evident within different models, in
response to different TiO2 samples. Therefore, in general
the inflammatory response that manifest is not organ, or
particle sample specific.
TiO2 mediated oxidative responses
A focus of a number of investigations has been to identify
the contribution of oxidative stress to the inflammatory
and cytotoxic responses elicited by TiO2. Studies previ-Page 14 of 27
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nent feature of the response to TiO2 NPs. These include
evidence of increased ROS production, depletion of cellu-
lar antioxidants, increase in oxidative products (such as
lipid peroxidation) or evidence that toxicity is diminished
on pre-treatment with antioxidants. These observations
have been made in a variety of cell types, including for
example; lung epithelial cells [26], fibroblasts [35], and
microglia [42]. A summary of the oxidative responses
mediated by TiO2 can be found in table 2.
It is acknowledged that the development of a moderate
level of oxidative stress is connected to the initiation of
inflammatory responses through the activation of ROS
sensitive signalling cascades [48]. Consequently Kang et
al. [49] compared the ability of nano (21 nm) and micro-
particulate (1 μm) forms of TiO2 (0.5-200 μg/ml) to initi-
ate an oxidative response within RAW 264.7
macrophages, following exposure for up to 24 hours. No
alterations in cell viability were observed on exposure of
cells to both forms of TiO2. This finding is of importance,
as when assessing the processes that underlie particle tox-
icity, sub-lethal concentrations are required. ROS produc-
tion was increased by TiO2, and was greatest in magnitude
for the NPs. The ROS sensitive mitogen-activated protein
kinase (MAPK) signalling pathway was activated by TiO2
exposure (indicated by ERK1/2 phosphorylation), which
was suggested to initiate the increase in pro-inflammatory
mediator production (TNFα, MIP-2). Within the end-
points measured, the response exhibited by NPs was con-
sistently greater than that of their larger counterparts,
when administered at an equivalent mass basis. The oxi-
dative stress paradigm therefore held true within this
study; specifically that particle mediated ROS production
(at a moderate level) stimulates signalling cascades that
promote the activation of transcription factors that, in
turn, initiate an inflammatory response. Accordingly, the
ability of particles to promote ROS production is thought
to be central to their ability to regulate inflammatory
responses.
In line with these findings, Xia et al. [50] investigated
whether TiO2 (11 nm), ZnO (13 nm), and CeO2 (8 nm)
oxidative stress development or particle dissolution con-
tributed to their toxicity. RAW 264.7 macrophages and
BEAS-2B epithelial cells were exposed to the NP panel for
up to 15 hours, at concentrations up to 60 μg/ml. How-
ever, only ZnO particles were capable of inducing cytotox-
icity, within both cell types. In addition, ZnO stimulated
an increase in ROS production, which in turn, increased
HO-1 expression, and activated the JNK signalling path-
way, which paralleled the release of IL-8 and TNFα.
Increased calcium release was also mediated by ZnO, and
was associated with mitochondrial damage. These find-
ings therefore imply that ZnO elicits an oxidant driven
response that was responsible for the initiation of an
inflammatory and cytotoxic response, which was absent
for TiO2 and CeO2. This is an important finding, as con-
trary to evidence that TiO2 can exhibit an oxidative medi-
ated response, this does not always transpire, and
therefore the experimental model and TiO2 sample may
be influential to the observed response. On the contrary,
CeO2 was able to stimulate a cytoprotective response,
whereby pre-treatment of cells with CeO2 protected
against diesel exhaust particle mediated cell damage
(which is known to be oxidant driven). All particle types
were internalised by an endocytic mechanism, however,
only ZnO accumulated within lysosomes, which was sug-
gested to drive their ability to inflict oxidative injury, and
promote particle dissolution. ZnO also induced
ultrastructural alterations, including nuclear fragmenta-
tion, apoptotic body formation and mitochondrial disap-
pearance. ZnO was therefore recognised as being the most
toxic particle within the panel, however this was thought
to be accounted for, in part, by their dissolution and
release of Zn2+ ions. The toxicity of the metal oxide parti-
cles was therefore suggested to be driven by their oxidant
properties, which was dependent on their composition,
dissolution and intracellular fate. The composition of NPs
has been demonstrated to be integral to their toxicity
within this study, and thus not all metal oxide particulates
are expected to behave similarly.
Lu et al. [51] had a slightly different focus and determined
the impact of TiO2 (0.2-3 mg/ml) on protein tyrosine
nitration (using bovine serum albumin (BSA) as a model
protein). Protein nitration was associated with TiO2 expo-
sure, in the presence of UV light, with anatase TiO2 sam-
ples being more photoactive than rutile forms.
Antioxidants, such as GSH and vitamin E were able to pre-
vent against the protein nitration observed. To determine
if proteins contained within mouse skin were targets for
TiO2 mediated nitrosation, similar tests were conducted
using mouse skin homogenate. Again, anatase forms of
TiO2 were observed to exhibit a greater propensity to nit-
rosate proteins. This study therefore highlighted the pho-
tocatalytic activity of TiO2, and the superior toxicity of
anatase forms, and demonstrated the ability of TiO2 to
induce nitrative stress.
Oxidative responses exhibited by TiO2 particles have been
a focus of a number of studies, and its recurrence has
prompted the suggestion that oxidative stress drives the
inflammatory and cytotoxic responses evident. It is rele-
vant that the level of oxidative stress, which is inevitably
related to the duration or concentration of particles
administered, drives the nature of the response that fol-
lows particle exposure. Specifically, at moderate levels of
oxidative stress, inflammatory responses may be stimu-
lated due to the activation of ROS sensitive signallingPage 15 of 27
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Table 2: The oxidative potential of TiO2
Paper Particle Model Endpoints Assessed Observation
Afaq et al., [46] TiO2 (<30 nm) Response of primary 
alveolar macrophages 
(following 
intratracheal 
exposure of rats)
Glutathione peroxidase,
glutathione reductase, glutathione-s-transferase 
activity
Intracellular GSH
Lipid peroxidation (thiobarbituric
acid reactive substances measured)
H2O2 production
Cytotoxicity 
(LDH assay)
Decreased GSH
Increased lipid peroxidation
Increased H2O2 
(indicative of respiratory bu
Increased glutathione pero
glutathione reductase
Decreased cell viability
Dunford et al., [58] TiO2 (extracted from 
commercially available 
sunscreens)
DNA oxidative 
damage (plasmid 
DNA & within MRC-
5 fibroblasts)
Oxidation of organic material (phenol)
Plasmid DNA (in vitro)
Comet assay 
(MRC-5 cells)
(all experiments conducted in sunlight illuminated 
conditions)
TiO2 stimulates oxidation o
materials (due to productio
radicals) & strand breaks in
DNA damage decreased w
quenchers (mannitol & DM
that it is oxidant driven
DNA damage observed in c
oxidant driven
Gurr et al., [28] TiO2 
(10, 20 or >200 nm)
BEAS-2B epithelial 
cells
Oxidative DNA damage (Comet assay)
Lipid peroxidation (MDA)
NO and H2O2 production
Cell viability 
(MTT assay)
Increased DNA damage
Increased lipid peroxidation
Increased NO & H2O2
Decreased cell viability
Responses only for 10 & 20
Jin et al., [35] TiO2 (20-100 nm) L929 fibroblasts Cell viability 
(MTT DH assays)
ROS production (dichlorofluorescein (DCFH) 
assay)
GSH & SOD cell levels
Decreased cell viability
Increased ROS production
Decreased GSH and SOD
Kang et al., [49] TiO2 (21 nm & 1 μm) RAW 264.7 
macrophages
Intracellular ROS generation (DCFH assay & 
dihydroethidium staining)
Cell viability (LDH)
Cytokine production
MAPK signalling pathway activation
No loss in cell
viability
Increased ROS production 
(greater for NPs)
Increased MIP-2 and TNFα
ERK1/2 phosphorylation 
(part of MAPK pathway)
Karlsson et al., [57] CuO (42 nm), ZnO (71 
nm), TiO2 (63 nm), Fe3O4 
(20-30 nm)
A549 lung epithelial 
cells
Cell viability 
(trypan blue)
ROS production (DCFH assay)
Comet assay
Cytotoxicity greatest for C
CuO increased ROS and el
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s
TiO2 NPs induce 
oxidative stress in cells, 
which is responsible for 
the observed 
inflammatory & 
cytotoxic (via 
apoptosis) responses
ytotoxicity
OS (ex vivo) production
-8 production
ependent on crystal form
Toxicity exhibited by 
TiO2 is phase 
dependent, and 
involves, oxidative, 
inflammatory and 
cytotoxic components
DA
atalase
SOD
rotein oxidation
s in other markers
TiO2 distributes within 
the brain and elicits 
oxidative damage, 
which is dependent on 
the crystal phase of the 
particles
 in cytotoxicity, ROS 
or inflammation was observed
The most toxic particle 
in the panel was ZnO. 
Toxicity was absent for 
TiO2.Long et al., [43] TiO2 BV2 microglia, N27 
neurones
ROS production (DCFH)
H2O2 production 
(Image-IT LIVE fluorescent probe)
Superoxide production 
(MitoSOX fluorescent probe)
Apoptosis (capase 3/7 activity & nuclear staining)
Increased R
Increased H
(rapid respo
Increased s
(later respo
Increased A
-Toxicity on
Lu et al., [51] TiO2 BSA Protein nitration (detected spectrophotomically & 
western blotting)
(experiments conducted with UV irradiation)
Protein nitr
Antioxidant
nitration
Park et al., [26] TiO2 (21 nm) BEAS-2B lung 
epithelial cells
Cell viability 
(MTT assay)
ROS production (DCFH assay)
GSH depletion
Apoptosis (caspase-3 assay & chromosome 
condensation)
Gene expression 
(RT-PCR)
Increased c
Increased R
Decreased 
Increased a
Increased e
(e.g. catalas
transferase)
TNFα) gene
Sayes et al., [71] TiO2 
(in various crystal forms)
HDF (dermal 
fibroblasts) & AA549 
(lung epithelial) cells
Cytotoxicity (LDH, MTT & live/dead assays)
Inflammation 
(IL-8 production)
Particle suspension ROS ex vivo production
Increased c
Increased R
Increased IL
-Response d
Wang et al., [17] TiO2 (in rutile (80 nm) & 
anatase (155 nm) forms)
Nasal Instillation
(mice)
Enzyme activity (gluthathione peroxidise, catalase, 
SOD, glutathione-S-transferase)
GSH levels
Lipid peroxidation (MDA)
Protein oxidation 
(protein carbonyl formation)
(All responses evaluated in the brain)
Increased M
Increased c
Decreased 
Increased p
-No change
Xia et al., [50] TiO2 (11 nm) (also ZnO 
(13 nm) & CeO2 (8 nm))
RAW 264.7 
macrophages & 
BEAS-2B lung 
epithelial cells
Cytotoxicity 
(Propidium iodide & MTS assays)
Intracellular ROS production (DCFH assay), and 
HO-1 antioxidant expression.
Pro-inflammatory signalling cascade activation 
(nfKB) and intracellular calcium concentration.
Cytokine production (TNFα & IL-8)
No increase
generation 
Table 2: The oxidative potential of TiO2 (Continued)
Particle and Fibre Toxicology 2009, 6:33 http://www.particleandfibretoxicology.com/content/6/1/33pathways [48]. At higher levels of oxidative stress, cytotox-
icity is evident, as cells are damaged by an overwhelming
burden of ROS [48].
Uptake of TiO2 into cells
The clearance of TiO2 particles by phagocytic cells has
been a particular focus of studies, due to their ability to
remove particles from the exposure sites, circulation or
secondary target sites. However, a number of non-phago-
cytic cell populations also have the propensity to internal-
ise particles. Considering the internalisation of particles
by cells is of relevance as particle uptake may enhance
their toxicity due to their interference with normal cellular
physiology and function. However, it is also possible that
particles act from outside the cell to elicit toxicity that is
mediated by interactions of particles with the cell surface.
Furthermore, particles can be internalised by cells and not
impact on cell function, which is likely to be driven by the
intracellular location in which they accumulate or the
extent of uptake.
Stearns et al. [52] demonstrated that 50 nm TiO2 (40 μg/
ml) was internalised by alveolar A549 epithelial cells into
membrane bound vesicles after 3, 6 and 24 hour expo-
sures. However, it was observed that the uptake of parti-
cles by these cells was limited to their aggregated form.
TiO2 internalisation was suggested to be mediated via
phagocytosis, due to the fact that plasma membrane pro-
jections surrounded and engulfed the particles prior to
uptake.
A focus of a number studies has been to reveal the contri-
bution of macrophage populations to the clearance of
particles, particularly within the lung. However, Geiser et
al. [53] argued that alveolar macrophages were not prima-
rily responsible for the uptake and clearance of NPs
within the lung in vivo. Rats were exposed to TiO2, via
inhalation (0.1 mg/m3), and alveolar macrophages were
isolated, and the internalisation of particles assessed, 1 or
24 hours post exposure. Large TiO2 particles (3-6 μm)
were more effectively cleared by alveolar macrophages,
than their smaller (20 nm) counterparts. Therefore TiO2
NPs were able to bypass the important alveolar macro-
phage mediated clearance mechanism within the lung,
due to their small size. These findings could be expected
due to the known size limitations of uptake processes
such as phagocytosis, which is thought to be restricted to
substances that are 1 to 5 μm in size [54]. The ability of
TiO2 NPs to evade phagocytosis was confirmed by the
findings that they were not enclosed by a vesicular mem-
brane equivalent to that surrounding the larger TiO2 par-
ticles. Therefore it was suggested that phagocytosis was
not responsible for NP uptake, and instead it was sug-
gested that a sporadic, non-specific mechanism of uptake
enabled NP uptake by macrophages. Alternatively it was
suggested that NPs were internalised unintentionally
when macrophages phagocytosed other material. The
findings of Geiser et al. [53] are also able to provide an
explanation for the finding that only TiO2 agglomerates,
and not individual NPs, were internalised by A549 cells in
vitro [52]. This was also recognised by Stearns et al. [52]
who highlighted that there was limited evidence of the
uptake of individual particles by cells. As Stearns et al. [52]
utilised epithelial cells, and Geiser et al. [53] used macro-
phages which are professional phagocytes, it is relevant
that the processes that drive particle uptake may be cell
specific, and reliant on their function.
Rothen-Rutishauser et al. [55] utilised an in vitro airway
wall model (triple cell co-culture), containing macro-
phages, epithelial, and dendritic cells to determine the
translocation of particles between the different cell types,
and to assess the intracellular fate of particles. Membrane-
bound aggregates (>0.2 μm) of TiO2 were evident within
all cell types. However, smaller aggregates (<0.2 μm) were
apparent within the cell cytoplasm, but were not mem-
brane bound, suggesting that the entry mechanism of par-
ticles was size dependent. However, it is relevant that the
behaviour of gold, and polystyrene particles was also
assessed, and it was found that their intracellular location
differed, which implied that different NPs are internalised
by different mechanisms or follow different intracellular
trafficking processes.
The uptake of TiO2 by a variety of cell types has been dem-
onstrated on numerous occasions. The consequences of
particle internalisation are anticipated to be oxidative and
cytotoxic in nature. It is anticipated that particle physico-
chemical properties may influence their internalisation by
cells. Accordingly, the size and surface charge of particles
has the ability to influence their uptake by cells. In addi-
tion, particle size and the cell type under investigation
also have the potential to determine the mechanism of
uptake and intracellular fate of particles.
Genotoxicity of TiO2
Evidence of genotoxicity has been previously encountered
within a number of studies; micronuclei development is
associated with TiO2 exposure, which is indicative of chro-
mosomal damage, DNA damage has also been observed
in response to TiO2 particulate exposure.
Rahman et al. [56] investigated the potential for TiO2 to
elicit DNA damage within SHE fibroblasts. Micronuclei
were evident within cells exposed to nano (<20 nm), but
not micro (>200 nm) TiO2 particles (exposed at concen-
trations up to 10 μg/cm2, for up to 72 hours), which insin-
uates that chromosomal damage has occurred. The NPs
also triggered the induction of apoptosis within cells,
which is recognised as a common response to DNA dam-
age.Page 18 of 27
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metal oxide NPs (copper oxide (CuO), ZnO, TiO2, Fe3O4)
to induce oxidative stress and DNA damage within A549
lung epithelial cells, at concentrations of up to 80 μg/ml
for a period of up to 18 hours. CuO and ZnO were able to
decrease cell viability, but TiO2 and Fe3O4 were not capa-
ble of eliciting such an effect. In addition, all metal oxide
particles, except Fe3O4 were able to elicit DNA damage, as
determined by the Comet assay. The CuO NPs were con-
sistently demonstrated to be the most toxic particle within
the panel, which was thought to be drive by their ability
to induce oxidative stress, and in turn DNA damage,
which prompted cell death. It was suggested that the
release of Cu2+ ions may contribute to the response, but
are not solely accountable for the toxicity of CuO NPs.
Importantly, this study illustrated that not all metal
oxides behave similarly, and that their dissolution was
able to contribute to their toxicity.
Dunford et al. [58] investigated the DNA damage inflicted
by a panel of TiO2 containing, commercially available
sunscreens on fibroblasts, when exposed for a period of
up to 60 minutes. It was demonstrated that, on sunlight
illumination, the ability of TiO2 to cause DNA damage
was enhanced in plasmid DNA and cells. Anatase forms of
TiO2 were more effective at inducing damage than rutile
forms. Mannitol (an antioxidant) was able to protect
against DNA damage, therefore implying that TiO2 medi-
ated ROS production is central to its genotoxic potential.
Consequently, absorption of UV light by TiO2 is thought
to stimulate ROS generation, which, in turn, leads to DNA
damage.
Nakagawa et al. [59] investigated the genotoxicity of a
panel of TiO2 NPs (in rutile and anatase forms, ranging
from 0.021 to 0.255 μm in diameter). A number of differ-
ent in vitro genotoxicity tests were utilised; a microbial
mutation assay (Salmonella typhimurium), the Comet assay
to detect DNA damage (mouse lymphoma L5178Y cells)
and a chromosome aberration assay (Chinese hamster
CHL/IU cells). TiO2 was used at concentrations up to
3200 μg/ml, with an exposure duration of up to 24 hours,
and experiments were conducted in the absence or pres-
ence of UV light. Without UV light, TiO2 NPs induced no,
or very limited genotoxicity. However in the presence of
UV light TiO2 elicited DNA damage and chromosome
aberrations (but no gene mutations) that was greatest for
anatase forms. The phototoxicity of TiO2 was therefore
realised in this study.
Theogaraj et al. [60] investigated the UV dependence of
the genotoxic potential of a panel of TiO2 NPs (in rutile
and anatase forms, all of which had a diameter of <60
nm). CHO cells, were exposed to TiO2 at concentrations
up to 5000 μg/ml for a period of 3 hours. In contrast to
previously discussed investigations, no chromosomal
alterations were observed within exposed cells, in the
presence or absence of UV light.
In a different approach, Driscoll et al. [61] determined if
there was a relationship between the inflammatory and
genotoxic potential of several particles; namely ufCB (14
nm), TiO2 (0.18 μm) and α quartz (0.9 μm). Rats were
exposed to particles via intratracheal instillation, at a dose
of 10 or 100 mg/kg, and analysis conducted 15 months
post exposure. All particle types induced the infiltration of
neutrophils into the lungs, indicating that particles could
induce an inflammatory response. Hypoxanthine-gua-
nine phosphoribosyl transferase (hrpt) gene mutation fre-
quency was increased within alveolar type 2 cells, on
exposure to particles. This response was replicated in vitro,
following the exposure of RLE-6TN alveolar epithelial
cells to BAL cells isolated from particle treated animals. It
was thus suggested that BAL cell derived ROS were respon-
sible for the mutagenic effects that transpired, and they
were suggested to derive from neutrophil activity. There-
fore the particle mediated neutrophillic driven inflamma-
tory response within the rat lung, was postulated to
increase the frequency of mutations within alveolar epi-
thelial cells, which was a dose and material dependent
finding. Accordingly, quartz was consistently found to
elicit the greatest genotoxic response, followed by carbon
black and then titanium dioxide, and this was related to
their inflammogenic potential. Therefore, the particles
themselves are not thought to be inherently genotoxic,
but the inflammatory response, and in particular neu-
trophil presence (and therefore increased oxidant burden)
instigated is anticipated to mediate this effect.
Concern regarding the genotoxic potential of TiO2, has
also emanated from findings that have illustrated that
tumours develop in vivo following a chronic exposure
regime ([13] see earlier). However, as stated previously
this is very much dependent on the exposure conditions,
and in particular the exceptionally high doses that were
administered within this model.
The ability of TiO2 NPs to inflict DNA damage has been
observed on numerous occasions, and is thought to be
driven by particle mediated ROS production, with cell
death often stimulated as a protective response. In addi-
tion, the manifestation of genotoxic events, as a secondary
consequence of an inflammatory response is also evident,
and requires further investigation. The appearance of TiO2
mediated genotoxicity appears to be influenced by the
crystal form of the sample, particle dissolution and light
conditions. The finding that chronic exposure to TiO2 can
induce tumours in vivo (under extreme exposure condi-
tions), also implies that the genotoxicity exhibited by
TiO2 is not limited to in vitro investigations.Page 19 of 27
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Evaluation of TiO2 NP effects on the reproductive system
is limited to one in vitro study.
Komatsu et al. [62] determined the potential for TiO2 NPs,
DEP and ufCB to impair the function of male mouse
reproductive system. This study evaluated the direct effect
of NPs on testis-constituent cells, and examined the effect
of TiO2 on mouse Leydig TM3 cells, the testosterone-pro-
ducing cells of the testis. TiO2 NPs (25-70 nm) at concen-
trations 1 to 1000 μg/ml were examined and uptake into
Leydig cells was detected using transmission electron
microscopy (TEM) or field emission type scanning elec-
tron microscopy/energy-dispersive X-ray spectroscopy
(FE-SEM/EDS). TiO2 was more cytotoxic to Leydig cells
than the other carbon based particles used in the study.
The proliferation of Leydig cells was suppressed tran-
siently by treatment with TiO2. TiO2 NPs were taken up by
Leydig cells, and in turn affected cell viability, prolifera-
tion and gene expression.
Only one available study examined the effects of TiO2 on
male reproductive physiology. The literature highlights
toxicity of TiO2 NPs to male Leydig; however investiga-
tions are limited in number and sample size, and there-
fore further studies would be required to confirm such a
finding. No literature examining TiO2 NP effects on
organs or cell types in the female reproductive system
were found.
Linking the physicochemical attributes of TiO2 
particulates to their pathogenicity or toxicity
As TiO2 particulates exhibit great diversity, with regards to
their size (and therefore surface area), composition, and
crystal form, it is necessary to outline what properties are
most influential in driving the toxicity of TiO2. However it
is also relevant to highlight that the experimental set up is
also able to influence the findings, including the choice of
species or cell type, method of exposure, and particle dis-
persal (see later)
Size dependency
Particle dimensions are recognised as being fundamental
to their toxicity. This derives from the fact that NPs have
been consistently demonstrated to be capable of eliciting
more pronounced toxicity than their larger (microparticu-
late) counterparts. The size dependency of TiO2 toxicity
has been frequently demonstrated [3,12,24,28,45,47],
and appears to be applicable to a variety of TiO2 forms,
and occurs regardless of the model used (table 3). How-
ever it is relevant that a high degree of particle aggregation
and agglomeration is associated with TiO2 administra-
tion, and so exposure to particles is unlikely to occur in a
'nano' form. However, what seems to be critical to the
toxic potential of particle samples is the size of particles
that make up the agglomerates. It is relevant that the terms
agglomeration and aggregation are often used inter-
changeably within the field of nanotoxicology. However,
some authors have suggested that NP aggregation and
agglomeration are distinct phenomena with agglomerates
Table 3: A summary of the size dependent toxicity of TiO2 particulates
Paper TiO2 Particle Size Model Findings
Ferin et al., [3] 21 nm
250 nm
Rats
Intratracheal instillation
Inhalation
Pulmonary inflammation greatest for NPs
Gurr et al., [28] 10-20 nm
200 nm
Bronchial epithelial cell line (BEAS-2B) NPs exhibit oxidative damage that is absent with fine particles
Kang et al., [47] 21 nm
1 μm
RAW 264.6 macrophages ROS production, ERK activation and pro-inflammatory 
mediator production (TNFα & MIP-2) greater for NPs
Renwick et al., [45] 29 nm
250 nm
J774.2 macrophages NPs impair macrophage phagocytosis, which is not apparent 
for fine particles
Renwick et al., [6] 29 nm
250 nm
Rats
intratracheal
NPs stimulate pulmonary inflammation (neutrophil 
infiltration), epithelial damage and cytotoxicity to a greater 
extent than their fine counterparts
The phagocytic ability of macrophages was impaired with NP 
exposure but not fine particles
Wang et al., [24] 25, 80 nm
155 nm
Mice
Oral administration
Toxicity (mainly observed within the liver & kidneys) was 
greater for NPs
Within the table NPs (equivalent to ultrafine particles, in terms of size) are defined as having a diameter that is less than 100 nm, and fine particles 
have a diameter of greater than 100 nm.Page 20 of 27
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electrostatic interactions, whereas aggregates are formed
from covalently fused or sintered particles that are not eas-
ily separated [63].
As discussed, the superior toxicity of nanoparticulate
forms of TiO2 has been repeatedly documented. However,
a study conducted by Dick et al. [64] illustrated that com-
pared to other NPs such as nickel, cobalt or carbon black,
TiO2 nanoparticles were less potent at inducing an inflam-
matory response within the lung, despite their similarity
in surface area. This was assumed to be related to their
lower capacity to generate free radicals, and therefore per-
haps particle composition and surface chemistry are also
important contributors to toxic responses [64].
Bermudez et al. [7] exposed rats to TiO2 via inhalation, to
investigate their pulmonary toxicity. Despite the fact that
the NPs had a primary particle size of 21 nm, the aerosol
generated contained particle aggregates (1.37 μm). This is
a common experience in the exposure of animals or cell
culture models to nanomaterials, and is likely to be
encountered within the exposure of humans. However,
despite the formation of aggregates, the NPs still exerted
toxicity. Similarly, aggregates of TiO2 NPs (1.44 μm) have
been demonstrated to be more toxic than similarly sized
aggregates of their larger counterparts [3]. However,
Grassian, et al. [10] demonstrated that the properties of
agglomerates of particles that formed during aerosol gen-
eration were dependent on the primary particle size. Spe-
cifically, 21 nm particle based agglomerates were less
dense than their 5 nm counterparts whose agglomerates
contained particles that were more tightly packed. It was
found that 21 nm TiO2 was more toxic than 5 nm particles
following inhalation and instillation exposure. The
agglomeration state of particles was therefore suggested to
dictate their toxic potential. Consequently, although 21
nm particles were larger, it is anticipated that they would
form agglomerates that would more easily deagglomerate
due to the weaker interactions that held the particles
together. As a result, 21 nm particles would be available as
smaller structures to stimulate an enhanced toxic
response. Furthermore the aggregates formed were larger
within inhalation preparations than intratracheal suspen-
sions, and so this may explain why intratracheal expo-
sures produced a greater toxic response.
The greater toxicity of NPs, compared to their larger coun-
terparts, is anticipated to be driven by the greater surface
area of smaller particles, when administered at an equiva-
lent mass dose. In fact, the surface area of particles has
been previously suggested to dictate the toxic potential of
particles [65-67]. In line with this hypothesis, Sager et al.
[68] addressed which dose metric was most influential in
driving the toxicity of TiO2; the surface area or mass of
particles administered. NPs (suspended in BALF) were
observed to agglomerate to a diameter of 200-300 nm
(despite having a primary particle size of 21 nm). This
finding emphasises that particle exposure often does not
occur in an individual particle form. Microparticle (1 μm)
and NP particles were able to induce an inflammatory
response (neutrophil infiltration, LDH activity, TNFα,
MIP and IL-1β release), subsequent to intratracheal
administration of rats. It was of interest that a higher mass
of microparticulate TiO2 was required to obtain the same
inflammogenic response as nanoparticle TiO2. Therefore,
the inflammatory and cytotoxic potential of NPs was
greater than that of microparticles, when administered at
an equivalent mass dose. However, when the dose of par-
ticles administered was equivalent, in terms of surface
area delivered (which necessitates the administration of a
much higher mass of microparticles), both particle types
behaved similarly. These findings suggests that the size,
and surface area of particles is integral to their toxicity.
Similarly, Sager et al. [69] determined whether the surface
area of ufCB and TiO2 NPs drives their inflammatory
potential. Particles were administered to rats via intratra-
cheal instillation, and toxicological observations made up
to 42 days post exposure. At equivalent surface area doses,
both particle types induced an inflammatory response
that was characterised by the infiltration of neutrophils at
day 1 which was of a similar magnitude. However the
response decreased with time for ufCB, but for TiO2 the
response was sustained in nature. This pattern of response
was similar for BALF protein levels. Consequently, the
composition of particles may also contribute to their tox-
icity. This observation remains debatable as others have
disputed this finding [11].
The size (and therefore surface area) of TiO2 nanoparticles
is known to be fundamental to their toxicity. The aggrega-
tion and agglomeration state of nanoparticles is also likely
to be influential to their toxicity. Consequently, it is often
the case that although the primary particle size is stipu-
lated by investigators; cells and animals are not exposed to
the particles in this form, [27,32,33,35,42,43,52,70-72].
However it is often observed that agglomerates/aggregates
of nanoparticles are more toxic than similarly sized
agglomerates/aggregates of their larger counterparts.
Therefore, the propensity of particles to aggregate has
prompted investigators to prevent against its occurrence
through the use of sonication, or inclusion of dispersants
such as within particle suspensions, but this also needs to
take into account what is relevant to human exposure.
Influence of TiO2 particulate surface chemistry/
modification/coatings to their toxicity
As for other nanoparticles, the surface of TiO2 particulates
can be altered through the attachment of surface moieties,
a process which is termed particle functionalisation. ThePage 21 of 27
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coating with aluminium oxide, or silica, which has gener-
ally been encountered within sunscreens to enhance pro-
tection from UV radiation [9].
Warheit et al. [9] investigated the impact of surface treat-
ments (alumina or silica) on TiO2 toxicity, within the
lungs (see earlier). It was demonstrated that those exhib-
iting the greatest toxicity, were those that contained the
highest aluminium oxide and/or silica content on the par-
ticle surface. However, overall it was observed that TiO2
particles induced low pulmonary toxicity, despite the abil-
ity of surface coatings to influence this.
Oberdorster [73] demonstrated that the surface properties
of TiO2 were able to influence their toxicity. This was dem-
onstrated via the intratracheal exposure of rats (500 μg/
animal, for 24 hours) to TiO2 (20 nm) that remained
uncoated (hydrophilic) or received a silane coating
(hydrophobic). The samples varied, with regards to their
inflammatory potency within the lungs, so that the
uncoated particles induced a lower response, than their
coated counterparts.
Hohr et al. [74] investigated the impact of surface proper-
ties on TiO2 toxicity. Microparticulate (180 nm diameter),
uncoated and coated (via methylation) NPs (20-30 nm
diameter) of TiO2 were exposed to rats, via intratracheal
instillation (1 or 6 mg/rat), and analysis conducted 16
hours post exposure. Administration of all particle types
stimulated the infiltration of neutrophils, with the effect
most pronounced with administration of NPs. It is also of
interest that the coated (hydrophobic) NPs tended to
stimulate neutrophil recruitment to a lesser extent than
the uncoated (hydrophillic) particles. Protein, LDH,
TNFα and MIP-2 levels in BAL also exhibited a similar pat-
tern, with regards to the potency of the different samples,
but overall the impact of surface methylation on TiO2 tox-
icity was negligible. However, it was concluded that the
toxicity of TiO2 was driven by the surface area of particles,
and not their surface coating. Therefore, a stronger inflam-
matory response was associated with NPs compared with
their larger counterparts and so the effect of methylation
was negligible.
Singh et al. [75] determined the impact of TiO2 size
(microparticles: 40-300 nm, NPs: 20-80 nm), surface
modification (using methylation, to make particles more
hydrophobic) and radical generating potential on their
uptake and toxicity within A549 lung epithelial cells. TiO2
particles, regardless of their size or methylation were
phagocytosed as clusters of particles. Internalisation of
NPs via clathrin mediated endocytosis, was only apparent
for small particle clusters that were less than 30 nm, illus-
trating that this may be a size dependent phenomenon.
ROS generation, and IL-8 production exhibited by cells
exposed to NPs was greater than that of microparticles,
and the findings were unaffected by the methylation of
the particle surface. An important observation was that
both particle types were present in an aggregated form,
and that the NPs were in a smaller size range (<500 nm)
than their larger counterparts (2000-5000 nm). Therefore
the superior toxicity of NPs held true, despite their ten-
dency to aggregate. Therefore, even when in an aggregated
form the toxicity of TiO2 particles was assumed to be pri-
marily driven by their surface area.
Thevenot et al. [76] determined the impact of TiO2 NPs,
with various surface modifications (-COOH, -OH or -NH2
functional groups), on the survival of a variety of cancer
cell lines. Exposure concentrations were high (up to 10
mg/ml) and occurred for a duration of 3 to 24 hours. The
cancer cell lines used were B16F10 and BF16F1
melanoma, Lewis lung carcinoma, JHU prostate cancer,
and 3T3 fibroblast cell lines. The different cell lines
showed different sensitivities to the cytotoxicity of TiO2
NPs. 3T3, B16F10 and BF16F1 cells were unresponsive to
all types of TiO2. However, TiO2 decreased the viability of
JHU and LLC cells in a dose dependent manner. In addi-
tion, by altering the surface chemistry of TiO2 particles,
the toxicity of TiO2 could be modified. In general, NH2,
and OH surface modified TiO2 exhibited greater toxicity
than COOH modified TiO2. This study therefore illus-
trated that TiO2 toxicity was very much dependent on the
cell type in question, the surface chemistry of TiO2 NPs,
and concentration of particles used.
Rehn et al. [70] illustrated that unmodified, or silane
coated forms of TiO2 were non toxic to the lungs. Rats
were exposed to the different forms of TiO2 (20 nm) via
intratracheal instillation (up to 1.2 mg/rat) and the
inflammatory and genotoxic effects within the lung were
determined, at 3, 21 and 90 days post exposure. All forms
of TiO2 were able to stimulate a modest increase in neu-
trophils and macrophages within the lungs (at day 3), but
this was not persistent in nature, and was not associated
with TNFα production. In addition, no genotoxicity was
evident with TiO2 exposure. In contrast, quartz induced a
persistent and progressive inflammatory response, with a
genotoxic element to the response also observed. How-
ever, the only genotoxic endpoint that was assessed was
the detection of 8 oxy-guanine, so perhaps a more com-
prehensive genotoxic study should be considered for
TiO2.
The modification of the surface of TiO2 particles is able to
influence its toxicity, however, this is likely to be depend-
ent on the modification, and cell type in question.
Crystallinity
TiO2 exists in two main crystal phases, termed rutile and
anatase. These TiO2 forms vary with regards to their crys-Page 22 of 27
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ble for differences within their toxicity [77]. Anatase has
been demonstrated to be the most toxic form of TiO2,
with a number of previously mentioned studies support-
ing this conclusion (see for example [17]). The photoac-
tivity of TiO2 is also dictated by the crystal phase, and
therefore surface characteristics of particles (such as oxy-
gen vacancies on the particle surface), with anatase forms
having a greater capacity to generate ROS on exposure to
light (see later). A summary of the contribution of particle
of crystallinity to TiO2 toxicity is demonstrated in table 4.
Sayes et al. [71] assessed the in vitro toxicity of anatase (10
nm), rutile (5 nm) or anatase/rutile (3 nm) TiO2 samples
to A549 epithelial cells and HDF fibroblasts, at concentra-
tions ranging from 3 μg/ml to 30 mg/ml, for up to 48
hours. The level of cytotoxicity exhibited by the different
particle types varied. Accordingly, anatase particles were
the most cytotoxic, while the rutile TiO2 particles were the
least toxic. This response was paralleled within the release
of IL-8 from cells. TiO2 particle stimulated ROS generation
and photoactivity was also greatest for pure anatase sam-
ples. Overall, the results implied that the anatase samples
had the greatest toxic potency. Consequently, the authors
suggested that it was the phase of TiO2 that was integral to
its toxic potential. Therefore, despite the relatively large
surface area of rutile TiO2 NPs (112 m2/g), their surface
chemistry is thought to be less reactive than that of ana-
tase samples (that had a larger surface area of 153 m2/g),
and so rutile particles are less toxic. The findings also sug-
gested that the ability of TiO2 particles to generate ROS,
governs their cytotoxic and inflammatory potential,
which is dictated by the crystal structure of TiO2, and
hence toxicity is not solely driven by surface area. How-
ever, rutile NPs were observed to agglomerate to the great-
est extent, and so this may also explain why this particle
type was observed to be less toxic. Although the findings
demonstrate that particle crystallinity is important to TiO2
toxicity, the relevance of the findings is questionable, as in
general, toxicity was only observed at higher concentra-
tions (greater than 300 μg/ml), which are not deemed to
be physiologically relevant (see later).
Pan et al. [72] investigated the toxicity of a panel of TiO2
particles to primary human dermal fibroblasts. Uncoated
rutile TiO2 (15 nm), polymer coated rutile TiO2 or
uncoated anatase TiO2 (200 nm) particles were exposed to
cells for up to 11 days, at concentrations up to 0.8 mg/ml.
Uncoated rutile TiO2 caused alterations in cell morphol-
ogy, so that cells had a smaller cell area, became elon-
gated, and detached from the culture surface. Anatase
TiO2 caused a greater magnitude of damage to cells, with
severe morphological changes observed including break-
age of actin filaments, and plasma membrane rupture
within exposed cells. Rutile TiO2 did not impact on cell
viability, but did slow cell proliferation rate but were
internalised by cells, and were contained within cytoplas-
mic vesicles. Anatase TiO2 was internalised by cells, and
could access the nucleus. H2O2 production by cells was
greatest with anatase particles, implying that their ability
to generate ROS was greatest within the TiO2 particle
panel. Anatase particles were therefore more potent that
rutile particles at inducing cell damage. Rutile particles
were then coated in order to prevent against particle adhe-
sion to the plasma membrane, and thus limit their poten-
tial for internalisation. Coated particles were not evident
on the cell surface, or within the cell interior. Conse-
quently, a polymer coating abolished particle toxicity,
which was suggested to derive from the lack of particle
adherence to the cell surface, and thus limited internalisa-
tion, so that they were unable to impact on normal cell
function. This study therefore demonstrates that particle
coatings, and therefore surface chemistry, are able to mod-
ify particle toxicity. However, this requires further investi-
gation, and may be dependent on the surface coating and
cell type in question.
The phase composition of TiO2 has been proposed to be
influential in dictating the toxic potency of particles. This
is likely to derive from their substantially different surface
chemistry, with anatase forms exhibiting the greatest pho-
tocatalytic and biological activity. The importance of crys-
tallinity, to the toxicity of particles has also been
demonstrated for SiO2 (see for example Kaewamatawong
et al. [78]).
Furthermore the ability of UVA or visible light to increase
the toxic potency of TiO2 particles, through increased ROS
production, has been a focus of a number of previously
discussed studies [see for example [36,51,58]], but does
not always transpire [38,60]. This phenomenon is antici-
pated to be exploited, particularly within the treatment of
cancer [36]. The crystal form of TiO2 has been suggested to
be responsible for driving the photoactivity of particles,
due to the importance of surface properties [77].
Quality of experiments conducted
The described studies vary greatly with regards to their
experimental set up. It has been highlighted that the size
of particles, their crystallinity, route of exposure, particle
concentration, experiment duration and species used can
all impact on TiO2 particle toxicity. Therefore, deciphering
what particle attributes are most influential to TiO2 toxic-
ity is challenging. For example, determining if the crystal
phase of TiO2 is primarily responsible for driving particle
toxicity is confounded by the fact that the different TiO2
samples under investigation will not just vary with regards
to their crystal phase but also, for example, their size and
surface area. Consequently, it is difficult to isolate specific
particle properties that are responsible for TiO2 toxicity,Page 23 of 27
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Table 4: The importance of crystallinity to TiO2 toxicity
Paper TiO2 crystal form Model Finding Toxic potency
Dunford et al., [58] TiO2 extracted from 
sunscreens (content ranging 
from 50/50 anatase/rutile, to 
100% anatase or rutile)
Pure Anatase (100%)
Pure Rutile (100%)
Oxidation of organic 
material (phenol)
DNA plasmids in vitro
Comet Assay 
(MRC-5 fibroblasts)
(ALL conducted in 
presence of sunlight)
TiO2 stimulates oxidation of 
organic materials (due to 
production of hydroxyl 
radicals), on illumination
Strand breaks in plasmid 
DNA. The damage 
suppressed by free radical 
quenchers (mannitol 
&DMSO) - illustrates that it is 
oxidant (hydroxyl) driven
DNA damage observed in 
comet assay, and again is 
oxidant driven
Anatase > rutile.
Derives from greater 
photocatalytic activity.
Lu et al., [51] Pure anatase (5 nm)
Pure rutile (50 nm)
Anatase/rutile mixture 
(21 nm)
Protein tyrosine nitration
(Conducted in presence 
of UV light)
TiO2 increased protein 
tyrosine nitration (indicative 
of oxidative and nitrative 
stress)
Anatase >anatase/rutile > 
rutile
BUT other physicochemical 
differences such as size were, 
not controlled for, which may 
contribute to response
Nakagawa et al, [59] Anatase form (21 nm)
Anatase form (255 nm)
Rutile form (255 nm)
Rutile form (420 nm)
In vitro genotoxicity 
assays:
Microbial mutation assay-
S. Typhimurium
Mammalian cell mutation 
assay (L5178Y cells)
Chromosomal aberration 
assay (CHL/IU cells)
(experiments conducted 
in presence or absence of 
UV light)
Weak genotoxicity in absence 
of UV light
With irradiation, TiO2 
particles were genotoxic in all 
tests
Anatase > rutile
Phototoxic component to 
response
21 nm anatase sample most 
toxic 
(illustrates that size may also 
contribute to response)
Pan et al. [72] Rutile (15 nm)
Anatase (200 nm)
Human dermal fibroblasts
Cell area, morphology & 
actin
Cell proliferation
Wound healing function
Cell migration
Particle internalisation
Cell morphology 
detrimentally affected and cell 
function impaired by TiO2
Anatase > rutile
Sayes et al., [71] Pure anatase
Anatase/rutile
Pure rutile
Human dermal fibroblasts 
and lung carcinoma cells
Cell viability (LDH, MTT)
Inflammation (IL-8)
Ex vivo ROS production
Cytotoxicity, ROS 
production & cytokine 
release is crystal phase 
dependent
Anatase greater than anatase/
rutile > rutile
Oxidant driven response & 
phototoxic component
Size of particles did not 
contribute to the response
Wang et al., [17] Rutile (80 nm)
Anatase (155 nm)
Mice (intranasal)
Particle distribution in 
brain
Neurone morphology & 
toxicity
Oxidative stress 
(lipid and protein 
oxidation)
Neurochemical levels
Accumulation of particles in 
brain
Both particle types 
translocate to brain
Anatase elicit greater 
neurotoxicity
anatase > rutile
Warheit et al., [11] Rutile
Anatase/rutile
Rats (intratracheal)
Inflammation 
(BALF cells, LDH, 
protein)
Histopathology
Pulmonary inflammation 
(nature, and length of 
response dependent on 
particle sample)
Rutile/anatase > rutile
Other factors such as particle 
size & agglomeration may also 
contribute to the response
Particle and Fibre Toxicology 2009, 6:33 http://www.particleandfibretoxicology.com/content/6/1/33and it is likely that a variety of factors act in concert to dic-
tate the toxic response observed. In line with this, it is also
vital for investigators to carry out relevant physicochemi-
cal characterisation of their particle sample. It is suggested
that prioritising the assessment of particle size, surface
area, composition (including surface chemistry), crystal
structure, and aggregation tendency would be of greatest
relevance, due to their apparent importance to particle
toxicity. If this is routinely carried out, this will facilitate
making comparisons between different investigations to
dissect out what particle attributes are driving the toxicity
of TiO2.
A frequent observation within existing studies, is that
excessively high concentrations of particles have been
administered to animals or cells. It is therefore essential
that investigators consider the relevancy of particle con-
centrations that are utilised, and justify their use if they are
excessively high, as otherwise the relevancy of experi-
ments is questioned. This is important as when adminis-
tered at a large concentration, overload effects dominate,
and the inherent toxicity of particles cannot be distin-
guished. For example, in vivo, this derives from the fact
that an excessive particle burden cannot be efficiency
cleared by defence mechanisms, and so the toxicity of par-
ticles is enhanced. In addition, the use of high particle
concentrations is particularly concerning when assessing
the toxicity of TiO2 to secondary target sites, such as the
liver, as these targets are anticipated to be exposed to
smaller concentrations of particles, due to the limited
translocation of particles into the circulation from expo-
sure sites. However, in saying this, wide concentration
ranges can provide valuable information regarding the
dose dependency of particle toxicity, and can also allow
for the generation of threshold doses. However, for ethical
reasons, the use of high concentrations should be
restricted for in vivo work.
Gaps in current knowledge have been identified within
the review, and thus there are a number of areas that
should be considered with priority in future investiga-
tions. There is a paucity of data relating to the systemic
transfer of TiO2 particles following exposure via the lungs,
skin and gut, and this should be a focus of future experi-
ments. Studies have focused on the dermal and pulmo-
nary toxicity of particles, but there is an absence of data on
the consequences of exposure to the GIT, and within dam-
aged/diseased skin. Other relevant target organs include
the liver, kidney, cardiovascular system and brain which is
required due to the fact that NPs are likely to become sys-
temically or neuronally available. The liver could be high-
lighted as a priority due to the propensity of particles to
accumulate in this organ.
Conclusions
Due to historical reasons, a focus on the size (and surface
area) dependence of TiO2 particulate toxicity has been
repeatedly investigated, and confirmation that particle
toxicity increases as particle size decreases has been con-
sistent within wide ranging investigations. However, it has
become evident that other physicochemical factors are
able to contribute to TiO2 toxicity; including particle
aggregation, crystal phase, and surface modification. The
exposure method, dose administered, species used, cell
type under investigation and light conditions also have
the potential to impact on the toxicity of TiO2 particles,
indicating that the experimental set up is also very influ-
ential to the toxicological observations. Therefore, making
generalisations about TiO2 particulate behaviour should
be approached with caution, and the findings from a lim-
ited number of studies should not be considered to be
representative for TiO2 particles as a whole. This is impor-
tant as particle characteristics and experimental set up
influence the toxicological observations made.
The toxicity of TiO2 has been demonstrated to have
inflammogenic, oxidative, and genotoxic consequences;
with these endpoints considered to be inherently linked.
It is of interest that the biological mechanisms identified
as being responsible for driving the toxicity of TiO2 partic-
ulates is replicated within in vivo and in vitro settings.
Cytotoxicity is also a common end point that is evaluated
within studies, although the relevance of this is question-
able (in terms of human exposure levels), except when
establishing sub-lethal concentrations for subsequent
studies that allow the identification of mechanistic proc-
esses that are responsible for toxicity. The ability of parti-
cles to exert toxicity at a variety of target sites is reliant on
their transfer into blood, and this should therefore be a
focus of future experimentation, as at this time, the sys-
temic availability of TiO2 particles following exposure is
uncertain. Accordingly, investigations into the toxicity of
TiO2 via specific routes of delivery, or at particular cell and
organ targets, are often insufficient in number to make
definite conclusions about particle behaviour. In addi-
tion, the quality (including the concentrations used,
experimental model), and relevancy of conducted experi-
ments is an important consideration, which is of vital
importance when considering the risk associated with
TiO2 exposure.
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